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ABSTRACT
 
The Effects of Probiotic and Eimeria on Gut Morphology and Humoral Immunity 
 in Broilers.  
(December 2010) 
Sadie Lyn Dunn Horrocks, B.S., Texas A&M Universtiy 
Chair of Advisory Committee: Dr. Morgan B. Farnell  
 Coccidiosis has a negative economic impact on the commercial poultry industry, 
and probiotics are beneficial bacteria that aid in maintaining healthy gut microflora.  We 
hypothesized that probiotic administration would positively affect gut morphology and 
increase IgG secretion during an Eimeria challenge, which was evaluated by measuring 
total chicken IgG and gut morphology (villus height, villus width, villus surface area, 
crypt depth, villus height to crypt depth ratio and lamina propria thickness).  
On day-of-hatch, broilers were placed into floor pens with 50% pine shavings 
and 50% used litter.  The broilers were exposed to Eimeria oocysts via the feed on day 
14 and challenged on day 36.  On days 6, 22, 36, and 43, tissue samples from the 
intestine were collected for morphological evaluation, and blood samples were taken to 
quantify chicken IgG from serum.  Data were measured using a factorial ANOVA and 
main effect means were deemed significant at P ≤ 0.05.  In cases where significant 
interactions were observed, data was subjected to a one-way ANOVA.  All means were 
separated using a Duncan’s Multiple Range Test.   
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On day 6 in the duodenum, a significant interaction was observed regarding 
vaccination and probiotic administration (Coccivac®-B, Intervet/Schlering-Plough 
Animal Health/Merck and Co., Inc., Whitehouse Station, NJ).  Villus height to crypt 
depth ratio decreased in ionophore treated birds compared to control birds in the 
duodenum and lower ileum on day 6, 36, and 43.  Villus crypt depth in vaccinated birds 
decreased in the duodenum after the challenge.  On day 43, the ionophore treated birds 
had less villus height and surface area compared to control and vaccinated birds, while 
lamina propria thickness increased in the duodenum, and non probiotic birds had longer 
villi than probiotic birds.   
On day 22, vaccinated birds had significantly increased chicken IgG levels 
compared to the control and ionophore birds, and the non probiotic birds had 
significantly increased IgG secretion compared to probiotic fed birds.  On day 36, the 
ionophore birds had significantly increased levels of IgG compared to the control birds, 
which could also support that the ionophore delayed exposure to the parasite.   
These results suggest that gut morphology and humoral immunity are affected by 
probiotic administration, coccidiosis vaccination, ionophore application and Eimeria 
challenge.  Both the day 43 morphology results and day 36 chicken IgG results for the 
ionophore treated birds demonstrates that ionophore administration delays exposure of 
the avian gut to invasive coccidia.  More research is necessary to evaluate how 
probiotics influence coccidiosis vaccination and humoral immunity, so that probiotics 
may be used to improve the effectiveness of coccidiosis vaccination and to evaluate if 
probiotics aid in ameliorating the effects of an Eimeria infection.    
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CHAPTER I 
INTRODUCTION 
Coccidiosis is an intestinal disease of poultry caused by the protozoan parasite 
Eimeria (Williams, 1998).  The disease has been estimated to cost the U.S. poultry 
industry approximately $3 billion U.S. dollars annually, which is attributed to the cost of 
in-feed anticoccidial drugs and production losses due to morbidity (decreased feed 
efficiency and body weight gain) and mortality (Dalloul and Lillehoj, 2006).  There are 
eight species of Eimeria known to parasitize chickens: Eimeria acervulina, E. brunetti, E. 
maxima, E. mitis, E. mivati, E. necatrix, E. praecox, and E. tenella (Conway and 
McKenzie, 2007).  Eimeria species are diverse and a challenge exists to control all species 
with one method (Lillehoj, 1988; Lillehoj et al, 1989).  Current Eimeria control methods 
include the use of in-feed anticoccidial drugs, such as ionophores.  Anticoccidial drugs 
have been used in poultry feeds as a means of controlling coccidiosis infections; however, 
drug resistance to anticoccidials exists throughout the poultry industry and though the 
mechanisms of drug resistance have been studied, they are not yet fully understood 
(Jeffers, 1974; McDougald, 1981; Chapman, 1982; Williams, 2006).   
Recent research has focused on developing vaccines to provide improved 
protection from Eimeria (Williams, 2002; Mathis and Broussard, 2006; Williams, 2006).  
Live oocyst vaccination is a viable alternative to anticoccidial drug use, because the 
vaccines have been shown to stimulate immunity to the parasite early in production,   
____________ 
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conferring protection (Williams, 1998).  Unfortunately, Eimeria vaccines are laborious and 
costly to produce because immunity to a single species of Eimeria does not protect the host 
against other species, so vaccines must include all species known to parasitize chickens in 
order to be completely effective (Dalloul and Lillehoj, 2005).  As drug resistance to 
anticoccidial drugs and reluctance to use Eimeria vaccines due to concerns for production 
losses continues, researchers must explore new, economical ways to improve current 
Eimeria control methods.  
Probiotics are defined as a live microbial feed supplement that benefits the host by 
improving the normal flora of the gut (Fuller, 1989).  The health of the gut is facilitated by 
normal bacterial flora, and probiotics have been shown to facilitate their mechanisms 
(Dalloul and Lillehoj, 2005).  Probiotics not only compete with pathogens for nutrients and 
attachment sites on the intestinal epithelium, but probiotics also secrete antibacterial 
factors, like volatile fatty acids, that can inhibit the growth and efficacy of pathogens 
(Nurmi and Rantala, 1973).  Probiotic supplementation has been shown to impact Eimeria 
infection by reducing oocyst shedding, increasing body weights, and up regulating 
secretion of Eimeria specific antibodies in broilers infected with E. acervulina and E. 
tenella (Dalloul et al., 2003; Lee et al., 2007).  However, the effect of probiotics on 
coccidiosis vaccination in broilers has not been reported.   
Probiotics have been shown to improve gut morphology and performance in 
broilers.  Research has shown that probiotics can increase surface area in the intestine 
available for nutrient absorption, while other research has shown improved feed efficiency, 
body weight gain and longer villus heights in the ileum with dietary inclusion of probiotics 
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(Samanya and Yamauchi, 2002; Awad et al., 2009; Eckert et al., 2010).  Longer villi 
indicate increased surface area for nutrient absorption and greater digestive capacity (Yang 
et al., 2007).  Villus height is also a morphological indicator of the integrity of the gut 
tissue, because longer villi are also indicative of active cell mitosis and enterocyte turnover 
(Samanya and Yamuchi, 2002).  Coccidiosis infection decreases absorption of nutrients in 
the small intestine when the parasite creates lesions in the wall of the epithelium and 
causes epithelial cell sloughing; this impairs growth and feed utilization (Dalloul and 
Lillehoj, 2005).  If probiotics can increase digestive capacity in the intestine, perhaps they 
could counteract some of the production losses that result from reduced gut surface area 
due to tissue destruction during a coccidiosis infection. 
Mountzouris and colleagues (2010) investigated the efficacy of Lactobacillus spp., 
Bifidobacterium spp., Enterococcus, and Pediococcus by evaluating digestive function, 
intestinal environment, and broiler health by measuring plasma antibody levels in addition 
to nutrient utilization, cecal microflora composition and performance parameters.  The use 
of probiotics may modulate the systemic immune system by increasing the total levels of 
serum IgG in broilers and be indicative of the overall humoral immune status of the bird 
(Mountzouris et al., 2010).  Koenen and colleagues (2002) also explored the effects of 
probiotics in the systemic humoral immune response, and found that different 
Lactobacillus spp. increase the levels of IgG in laying hens.  The role of humoral immunity 
during coccidiosis, however, has yet to be clearly defined (Dalloul and Lillehoj, 2005).    
The objectives of the current research was to compare current coccidiosis control 
methods, like in-feed ionophore application and live oocyst coccidiosis vaccination, to 
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probiotics, to examine how each of these treatments behaved when applied together, and to 
observe how each treatment was affected by a field strain Eimeria challenge.  The 
investigators measured the effects of each treatment on the architecture of the gut tissues 
by evaluating gut morphology, and also measured the effects of each treatment on the 
humoral status of the bird by quantifying IgG levels in serum.   
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CHAPTER II  
 
REVIEW OF LITERATURE 
 
Introduction 
 Coccidiosis is an intestinal disease of poultry caused by the protozoan parasites of 
the genus Eimeria, in the phylum Apicomplexa (Levine, 1982).  These parasites are 
obligate intracellular parasites that are transmitted via the fecal-oral route, and are 
especially important in commercial broilers due to the intense rearing strategies and 
environmental conditions in poultry houses (Shirley et al., 2005).  High stocking densities, 
typical of commercial poultry rearing barns, and the warm, moist environment created in 
poultry litter are conducive to the propagation of Eimeria (Williams, 2002).  The presence 
of Eimeria is an important economic issue for producers not only because clinical 
coccidiosis can cause weight loss and mortality, but also because the cost of disease 
prevention and treatment is high (Shirley et al., 2005).  In fact, the cost of coccidiosis to 
the poultry industry worldwide is estimated to be approximately 3 billion U.S. dollars 
annually (Dalloul and Lillehoj, 2006).  Protecting poultry flocks from coccidiosis depends 
largely on the development of protective immunity to the resident Eimeria species present 
in a location.  Since commercial broiler chickens only live for six weeks before slaughter, 
it is necessary to develop and explore new, effective methods of control for coccidiosis in 
order to protect producers from production losses before the birds are able to fully develop 
protective immunity (Shirley et al., 2005).   
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 Eimeria Life Cycle 
The coccidia parasite in birds was first reported by Fantham in 1910 (Chapman, 
2003).  Eimeria spp. has complex life cycles that include three phases: sporogony, 
merogony, and gametogony (Long, 1982).  Depending on species, the endogenous phase in 
the intestine (which includes merogony and gametogony) consists of multiple stages of 
asexual reproduction, also called schizogony, which is followed by sexual differentiation, 
fertilization, and shedding of unsporulated oocysts (Lal et al., 2009).   
The exogenous phase (sporogony) occurs in the environment, where excreted 
oocysts are stable and eventually sporulate to become infective (Lal et al., 2009).  The 
infective oocyst is stable in the environment for several months due to its thick wall, 
making eradication of the parasite with disinfectant nearly impossible (Shirley, 1993).  The 
oocysts contain a diploid single cell called a sporont, which undergoes a reduction division 
in the presence of oxygen which allows it to ―throw off‖ its polar body and begin 
sporogeny (Levine, 1982).  Infection begins after the mature oocyst is ingested and excysts 
in response to conditions in the host (Levine, 1982).  In the gizzard, mechanical grinding 
releases the sporocysts into the lumen.  Then, bile and trypsin stimulate the release of the 
sporozoites from the sporocysts via the operculum into the lumen of the duodenum 
(Levine, 1982).  The sporozoite is the infective stage of the parasite and after release from 
the sporocysts they move to the base of the intestinal epithelial cells lining the villi, where 
the sporozoite will use proteolytic enzymes to penetrate the host cell.  Sporozoites are first 
observed in intraepithelial lymphocytes (IELs) and then develop inside epithelial cells 
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because host IELs have been shown to transport the sporozoites from the villi to the 
intestinal crypts (Fernando et al., 1987; Trout and Lillehoj, 1996).  While in these cells, the 
sporozoite develops into a rounded body called a first generation trophozoite, then it grows 
into a first generation schizont, the asexually reproducing stage of the parasite.  Eimeria 
brunetti and E. praecox undergo the entire endogenous phase (both merogony and 
gametogony) in these villus enterocytes while other Eimeria species develop in enterocytes 
located in crypts before infecting superficial enterocytes during successive stages of 
shizogony (Shirley et al., 2005).  The first generation schizont divides into many first 
generation merozoites.    
Merogony beings when one sporozoite releases approximately 1,000 first 
generation merozoites into the gut lumen, a cycle which repeats 2-4 generations depending 
on species (Yun et al., 2000).  This rupture of intestinal epithelial cells creates extensive 
cell damage and inflammation in the host and is the basis for the pathologic signs of 
coccidiosis (Yun et al., 2000).  Once in the lumen, merozoites penetrate other epithelial 
cells and develop into second generation trophozoites, which develop into second 
generation schizonts.  The new and numerous schizonts release second generation 
merozoites which invade new epithelial cells.  Each new generation of schizonts results in 
the production of more merozoites leading to widespread infection.   
Gametogony occurs when merozoites develop into either microgamonts or 
macrogamonts and form a zygote encased by a thick wall that maintains the viability of the 
oocyst in harsh external environments (Yun et al., 2000).  Once outside the host, oocysts 
remain viable in the environment for long periods of time before being ingested and 
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starting the life cycle again (Yun et al., 2000).  Though gametogony can induce partial 
immunity, the early endogenous stages are considered the most immunogenic (Shirley et 
al., 2005).  Currently, there are eight species of Eimeria that parasitize chickens: Eimeria 
acervulina, E. brunetti, E. maxima, E. mitis, E. mivati, E. necatrix, E. praecox, and E. 
tenella; however, each species differs in its pathology and immunogenicity (Chapman, 
2000; Conway and McKenzie, 2007).  The Eimeria life cycle contributes to the 
complexities of host immunity to the parasite, which involves innate and acquired immune 
systems (Lillehoj, 1998).       
Pathology and Site Specificity of Eimeria 
Each species of Eimeria is characterized based on differences in biology, such as 
development, infection site specificity and life-cycle stages (Schnitzler and Shirley, 1999; 
Chapman, 2000; Shirley et al., 2005).   Different species of Eimeria are site specific in the 
intestine.  McDougald and Reid (1997) reviewed the localization of different Eimeria 
species.  Infections of E. acervulina are the most common of commercial poultry in the 
U.S. and localize in the duodenum, as well as infections with E. praecox and E. mivati, 
though E. mivati can localize in the duodenum and upper ileum.  Eimeria maxima and E. 
necatrix localize in the upper ileum, but small numbers of E. necatrix oocysts can be found 
in the lower ileum and ceca.  Localizing in the lower ileum and large intestine, E. brunetti 
causes bloody enteritis, while E. mitis localizes in the lower ileum and lacks discrete 
lesions.  Infections with E. tenella are localized in the ceca and are characterized by severe 
hemorrhaging and high morbidity in commercial broilers.  Furthermore, Eimeria spp have 
been found to disseminate beyond the digestive tract in some cases, where investigators 
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suspect the parasite was able to reach and infect liver tissue via the biliary system 
(Rodriguez et al., 2007).   
All Eimeria species can contribute to production losses, and though they may not 
all cause mortality, the morbidity associated with coccidiosis is relevant to poultry 
producers and has a negative economic impact on the industry.  Meronts, gamonts, and 
oocysts can all induce histological alterations in host cells including distortion, 
inflammation, rupture, and intestinal cell sloughing, which contribute to clinical 
coccidiosis (Yun et al., 2000).  Clinical signs of coccidiosis include diarrhea, dehydration, 
malabsorption, rectal prolapse and mortality.  These effects are deleterious to production 
because they disrupt digestive processes which eventually cause weight loss and poor feed 
efficiency (McDougald and Reid, 1997; Allen and Fetterer, 2002).   
Each species’s immunogenicity and pathogenicity also differ, for example, the 
number of oocysts are required to generate an immune response varies between species.  
Eimeria  maxima is highly immunogenic and only a small number of oocysts are required 
to achieve complete immunity, while less pathogenic species, like E. praecox or E. mitis, 
require a higher number of parasites to be present in the environment to generate immunity 
(Chapman, 1999; Chapman, 2000).  Factors such as intensive rearing practices in broilers 
also increase the incidence of more prevalent species, like Eimeria maxima, E. acervulina 
and E. tenella (McDougald et al., 1997).  In order to establish complete protective 
immunity to any species of Eimeria, fecal-oral re-infection is critical, but once re-infection 
occurs, post infection immunity is long lasting (Chapman and Cherry, 1997; Yun et al., 
2000).  The early endogenous phases of the life cycle are considered to be the most 
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immunogenic and are critical to development of immunity.  Rose and Hesketh (1976; 
1987) determined that the second generation schizont stage of an Eimeria maxima 
infection was the most associated with inducing protective immunity, followed by E. 
brunetti and E. praecox.  The ability to manipulate immunity to coccidiosis based on 
different stages of the life cycle illustrates the importance of understanding immunity to 
better control the parasite.      
Mucosal Immune System 
The immune system is the collection of cells, tissues, and molecules that 
coordinates reactions to mediate infection resistance and antigen elimination (Abbas and 
Lichtman, 2006).  The immune system is separated into two major mechanistic groups: the 
innate immune system, which mediates the initial protection from infection, and the 
adaptive immune system, which develops more slowly but is specific and more effective in 
antigen elimination (Abbas and Lichtman, 2006).   Both the innate and adaptive immune 
systems depend on the activity of leukocytes, and there is cooperation between the 
leukocytes of each system so they can eliminate pathogens (Janeway et al., 2001; Beutler, 
2004).   
The body has several secondary lymphoid tissues that serve as sites for leukocyte 
and pathogen interactions, like the mucosal lymphoid tissues (Abbas and Lichtman, 2006).  
The mucosal associated lymphoid tissues are comprised of lymphoid tissues located in the 
nasal passages, bronchial organs, genital tract, and gut associated lymphoid tissue (GALT), 
that house leukocytes; these leukocytes seek and eliminate pathogens at ports of entry to 
the host (Yun et al., 2000).  The GALT is a multilayered tissue that is continuously 
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exposed to antigens from food, normal microbial flora, and ingested pathogens.  The outer 
layer of the GALT consists of epithelial cells and lymphocytes above the basement 
membrane which maximize antigen/host cell exposure, and lamina propria lymphocytes 
below the basement membrane, which is a mucosal effector site (Mowat and Viney, 1997; 
Yun et al., 2000).  Poultry have specialized aggregates of lymphoid tissue within the 
GALT like Peyer’s patches, cecal tonsils and the bursa of Fabricius that contain effector 
cells to eliminate pathogens; these tissues and cells are the basis for the development of 
protective immunity (Yun et al., 2000).     
Avian GALT and Immunity to Eimeria 
Defined lymph nodes are absent in most birds, however birds do have a well 
defined lymphatic system comprised of nodular aggregates of lymphoid tissue, like the 
GALT, strategically positioned along lymphoid vessels to drain the skin, gut, and lung to 
provide an interface between antigens and immune cells.  The GALT has evolved special 
features that reflect its role as the first line of defense on mucosal surfaces which include 
the presence of antigen presenting cells, immunoregulatory cells, and effector cell types 
distinct from their counterparts in the systemic immune system (Lillehoj and Trout 1996; 
Lillehoj and Lillehoj, 2000; Yun et al., 2000).  In chickens, a variety of specialized 
lymphoid organs (thymus, Peyer's patches, cecal tonsils, and bursa of Fabricius) and cell 
types have developed in the GALT to defend against intestinal pathogens like Eimeria 
(Lillehoj and Trout, 1996).  The avian GALT serves three functions in host defense against 
enteric pathogens: processing and presentation of antigens, production of intestinal 
antibodies, and activation of cell mediated immunity (Dalloul and Lillehoj, 2005).  It takes 
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approximately 3-4 weeks for chickens to acquire immunity to coccidiosis and during that 
time the infection can extensively impact mortality in a poultry flock (Schnitzler and 
Shirley, 1999).  The immunity acquired during infection with one species of Eimeria will 
not protect hosts against infection with any of the other species, so the immune system is a 
key mediator in parasite elimination (Williams, 1998; Yun et al., 2000).  Both cellular and 
humoral immune mechanisms are involved in Eimeria immunity development, and the 
avian GALT is largely responsible for initiating these mechanims.    
Janeway and colleagues described the maturation of thymus dervided lymphocytes 
(T cells) as a unidirectional migration of immature T cells that forces interactions between 
developing T cells and self and non self antigens in order to elicit T cell maturation (2001).  
Immature T cells migrate to the thymic cortex where the immature T cells first express a 
complete T Cell Receptor (TCR), which allows the cell to recognize foreign antigens.  
Poultry have proportionately greater numbers of γδTCR than other animals, and the 
greatest numbers of these cells are found within the GALT (Lillehoj and Trout, 1996).  
Chicken γδTCR appears in the thymus at 11 days post embryonic development, and they 
appear in the intestine by days 14-15 (Dunon et al., 1993). Development of TCR is 
followed by maturation into either CD4 or CD8 positive cells, which will determine their 
function.  For example, CD4 T cells will aid in the activation of macrophages and B cells, 
while CD8 T cells are responsible for killing infected host cells and also activating 
macrophages (Abbas and Lichtman, 2006).  Then, T cells are exposed to host major 
histocompatibility complex (MHC) molecules and are either selected or die depending on 
whether they are able to recognize MHC; T cells unable to recognize self MHC will be 
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unable to eliminate pathogens (Abbas and Lichtman, 2006).  The process ensures that CD4 
T cells will recognize MHC class I molecules and that CD8 T cells recognize MHC class II 
molecules (Abbas and Lichtman, 2006).  The T cells that survive the maturation process 
will be able to successfully recognize foreign antigens, tolerate self antigens, and express 
surface markers to carry out effector functions. Mature T cells will interact with 
macrophages and other effector cells to secrete cytokines and pro-inflammatory molecules 
that direct the appropriate immune responses to antigens (Dalloul and Lillehoj, 2005).  
Cell mediated immunity is highly effective against coccidiosis infection and is 
mediated mostly by intestinal intraepithelial and lamina propria lymphocytes (Yun et al., 
2000).  Research has demonstrated increased levels of CD4 and CD8 T cells during an 
Eimeria infection, accompanied by T helper cells producing interferon gamma (IFNγ), 
which is an important part of the avian immune system due to its role in activation of 
lymphocytes and expression MHC class II (Kaspers et al., 1994; Bessay et al., 1996).  
Trout and Lillehoj (1995; 1996) also reported the importance of CD8 intraepithelial 
lymphocytes during coccidiosis.   By using immunoflorescence, the investigators were able 
to observe these cytotoxic cells directly interacting with host cells infected with Eimeria in 
order to eliminate them.  Additionally, the expression levels of gene transcripts encoding 
for pro-inflammatory cytokines are up regulated in epithelial lymphocytes in the GALT 
during coccidiosis, demonstrating that T cells are mediating the infection while recruiting 
the other cells responsible for inducing inflammation to the site of infection (Park et al. 
2008; Hong et al., 2006).   
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The avian bursa of Fabricius is located dorsal to the diverticulum of the proctodeal 
region of the cloaca.  Like T cells, B cells undergo a similar, stringent selection process 
during their maturation, though they are not MHC restricted.  Only about 5% of the B cells 
in the bursa ever leave, but these selection mechanisms are not as thoroughly understood as 
the selection mechanisms in the thymus.  Mature B cells, when activated, will secrete 
immunoglobulins (Ig).  Immunoglobulin G (IgG) is absent in birds, however, a monomeric 
Ig protein similar to IgG with an extra carbohydrate domain in the Fc region called IgY is 
present.  Chicken IgG (IgY) is stored in the yolk and is the only source of maternal 
antibodies for chicks.  After initial exposure to commensal bacteria, Peyer’s patches in the 
GALT act as the inductive site of the secretory antibody response (Pickard et al., 2004).  
Researchers believe that repeated exposure to microflora and, eventually, foreign antigen 
stimulates the class switch between antibody producing B cells (Kiyono et al., 1985).  In 
the lumens of mucosal organs, secretory IgA (sIgA) can be produced by B cells in the 
GALT, while systemically chicken IgG and IgM mediate infection (Janeway et al., 2001; 
Bar-Shira et al., 2002; Abbas and Lichtman, 2006).   
Upon exposure to Eimeria, chickens produce IgM, IgA, and chicken IgG (Dalloul 
and Lillehoj, 2005).  Chicken IgG is concentrated in the yolk sac of the egg and is 
transported to the embryo late during development, and these maternal antibodies have 
been reported to provide some passive immunity to Eimeria (Lillehoj, 1987; Lillehoj et al., 
2004).  Rose and Long (1971) explored the protective effects of transferring immunity to 
chick embryos.  The authors found that antibodies provided protection from E. tenella 
infection only when the ―donors‖ (hens) were actively developing immunity to E. tenella 
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(Rose and Long, 1971).  Though the investigators felt that the result of maternal 
transmission of protection to embryos was inconclusive due to testing methods used at the 
time, they did note oocyst output reduction in the progeny of immunized hens when chicks 
were challenged at 4 days of age with E. tenella oocysts (Rose and Long, 1971).   
In the 1990s, several investigators (Wallach et al., 1992; Smith et al., 1994a; Smith 
et al., 1994b; Wallach et al., 1995) reported that although maternal immunity to E. maxima 
infections decreased gradually over time, which was show in decreased IgG titers in egg 
yolk and chick sera, maternal antibodies still play a significant role in protecting the chick 
at the time of hatch.  Parasite specific IgG could be transferred to chicks in the yolk, and 
protect against infection for the first 2-3 weeks outside of the egg (Rose and Long, 1971; 
Rose, 1972).  Early protection against infection could be beneficial, especially in broilers, 
because immunizing one breeder hen could provide protection to numerous broiler chicks 
(Smith et al., 1994b).  Also, though maternal immunity is considered almost non-existent 
by 3 weeks of age, Smith and colleagues (1994b) asserted that these chicks would be 
protected long enough to prevent severe coccidiosis before slaughter.  Investigators also 
found that oocyst output in hatchlings that were progeny of immunized breeding hens was 
reduced after a challenge with E. maxima oocysts (Smith et al., 1994a; Wallach et al., 
1995).  Wallach and colleagues (1995) also determined that chicks immunized with 
affinity purified gametocyte antigens from Eimeria maxima were not only immunized to 
Eimeria maxima, but also partially immunized to infections with E. tenella and E. 
acervulina.  These parasite specific maternal antibodies serve a role in humoral immunity 
by reducing infectivity as a consequence of parasite neutralization, and the ability to 
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modulate these antibodies would provide a means of decreasing the invasive potential of 
Eimerai (Lillehoj and Lillehoj, 2000).   
Secretory IgA in the intestinal lumen can also induce stearic hindrance, reducing 
parasite motility by changing the conformation of the parasite’s host cell receptor 
molecules, and/or inhibit intracellular parasite development (Yun et al., 2000).  Bursa cells 
begin producing parasite-specific antibodies shortly after infection, and, upon repeat 
exposure to Eimeria, class switching to Immunoglobulin A (IgA) in effector B cells does 
occur under the influence of Interleukin-5 (IL-5) from T helper cells (Lillehoj and Ruff, 
1987; Rose and Hesketh 1987).  Overall, the ability of antibodies to mitigate coccidiosis is 
considered to be minimal, since investigators have reported bursectomized birds remain 
resistant to coccidia re-infection (Lillehoj, 1987).  Investigators have used immunoglobulin 
(chicken IgG, IgA and IgM) levels in serum samples to collect information about the 
humoral immune status of chickens (Mountzouris et al., 2010). Instead, chicken IgG can be 
an indicator of the overall humoral status of the bird during a coccidiosis infection 
(Mountzouris et al., 2010).   
 Peyer’s patches (PP) are nodules of lymphoid tissue within the submucosa in the 
ileum of the small intestine.  They have a morphologically distinct lymphoepithelium with 
follicles, B cell dependent subepithelial zones, and T cell dependent central zones, both 
encapsulated in germinal centers, while the overlaying specialized epithelium has 
thickened villi, and lack goblet cells (Befus et al., 1980; Burns, 1982).  Modified microfold 
cells (M cells) nestled within the intestinal epithelium are capable of uptaking antigens 
from the lumen by endocytosis.  Microfold cells lack a surface glycocalyx and do not 
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secrete mucus, so they are adapted to interact directly with molecules and particles within 
the lumen (Janeway et al., 2001).  The basal membrane of M cells delivers antigens 
directly to lymphocytes and DC within the lymphoid compartment of PP, so when antigens 
are transported through M cells via transcytosis they are immediately directed to antigen 
presenting cells (APC) expressing MHC II that will activate T and B cells (Premier and 
Meeusen, 1998).  Activated lymphocytes migrate from the PP to the lamina propria and 
intestinal epithelium where they act out their effector mechanisms.   
The cecal tonsils are the largest aggregate of GALT in the chicken (Lillehoj and 
Lillehoj, 2000).  Located at the ileocecal junction, the immune properties of the cecal 
tonsils develop post-hatch in response to antigenic stimulation (del Cacho et al., 1993).  
Vervelde and Jeurissen (1995) illustrated that during an Eimeria tenella infection, there are 
increased numbers of leukocytes in the cecal tonsils, but the mechanisms involved are not 
fully understood.  The majority of lymphocytes present in the cecal tonsils are B cells for 
antibody production, which are predominately chicken IgG cells (Befus et al., 1980; 
Lillehoj and Trout, 1996).  Mountzouris and colleagues demonstrated that measuring 
chicken IgG production in serum can be a useful tool in determining the overall humoral 
immune status of a bird from a systemic perspective during an infection, since different 
antibodies can be localized and produced within the GALT (Bowman et al., 2002; 
Mountzouris et al., 2010).   
Intraepithelial lymphocytes are present in the epithelium and the lamina propria, 
and consist of mostly CD4 T cells and some IgA B cells (Befus et al., 1980).  
Intraepithelial lymphocytes have the highest percentage of γδTCR in the GALT, are able to 
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directly recognize intracellular pathogens and damaged cells (Bandeira et al., 1991; Yun et 
al., 2000).  Janeway and colleagues discussed the γδTCR population in the gut and 
explained that these cells do not bind to normal MHC peptide ligands, but instead, they use 
an activating C-type lectin NK receptor (NKG2D) that binds two MHC-like molecules 
(MIC-A and MIC-B) that are expressed on epithelial cells in response to cellular injury, 
infection and stress (2001).  This subset of T cells patrols the body to eliminate these.   
The lamina propria is an epithelial tissue that constitutes the basement membrane 
of the gut, and it contains lamina propria lymphocytes that are mostly activated CD8 T 
cells which lyse infected host cells (Lillehoj and Trout, 1996).  The thickness of the lamina 
propria tissue can relate to pathogen resistance.  Tellez and colleagues (1993) noted that 
Salmonella enteritidis-immune lymphokines conferred resistance to S. enteritidis 
infectivity.  The investigators associated the increase in the lamina propria tissue thickness 
with inflammatory cell infiltration, and determined that the infiltration was initiated by 
mucosal invasion by the pathogen.  Avian heterophils, specifically, are equipped to 
respond rapidly to intracellular invaders, and destroy infected cells.  Therefore, the 
morphology of the lamina propria tissue is vital to facilitating pathogen elimination. 
  Non-specific factors that can prevent infection include physical barriers, 
phagocytes and leukocytes, and the complement system.  Eimeria enters host cells by 
penetrating mucosal epithelial cells, significantly compromising the physical integrity of 
the gut (Yun et al., 2000).  Yun and colleagues (2000) explained the importance of 
intestinal epithelial cells during a coccidiosis infection in three parts: 1) epithelial cells 
absorb nutrients from the digesta; 2) they are the ―first line of defense‖ against ingested 
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pathogens since they are continuously exposed to environmental antigens; and 3) intestinal 
epithelial cells constantly experience cell death and regeneration, which means they can act 
as a selective barrier that can resist and eliminate pathogens.  The gut morphology can be 
indicative of the integrity of the gut during an infection; more specifically, the villi are an 
indicator of the effectiveness of the digestive and absorptive processes, especially in the 
highly active small intestine (Aptekmann et al., 2001).  Highly mitotic enterocytes 
replicate in the villus crypts, and as they multiply, enterocytes migrate toward the villus 
base, pushing other cells apically to the lumen; this creates a continuous supply of new, 
maturing absorptive cells (Aptekmann et al., 2001).  Dunsford and colleagues (1989) 
showed that reduced villus height can indicate enterocyte destruction, especially during a 
pathogen invasion.  Tellez and colleagues (1993) also examined gut tissues during 
infection and found that significant increases in lamina propria thickness are not only 
associated with pathogen resistance, but also the lamina propria tissue is the basement 
membrane for the intestinal villi, so it serves as structural support for the villi.  Better 
villus integrity can also aid in counteracting the clinical effects of infection, like the weight 
loss and malabsorption seen during coccidiosis.   
In poultry, some adaptive physiological mechanisms exist in the intestine during 
coccidiosis infection.  Ruff and Wilkins (1980) noted an increase in absorptive capacity of 
the intestine, especially in the uptake of glucose and methionine, early during the recovery 
phase.  Turk (1974) also noted increased weights in all segments of the small intestine 
during a coccidiosis infection.  These physiological changes within the host during 
parasitism is attributed the host to compensating for decreased surface area in the intestine 
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(Hoste, 2001).  These mechanisms illustrate the importance of intestinal morphology 
during a coccidiosis infection.  If the integrity of the gut tissue can be improved, the 
intestine will not only be more resistant to pathogen invasion, but also it will increase the 
performance of the bird.  Birds with longer villi and greater surface area have a greater 
absorptive capacity for nutrients which aids in offsetting the negative effects of coccidiosis 
(Awad et al., 2009; Yang et al., 2007). 
Ionophores 
Prophylactic drugs have been used as anticoccidial feed additives for over 50 years 
and are classified as either chemicals with specific modes of action against parasite 
metabolism or as polyether ionophores which act by altering ion transport and disrupting 
osmotic balance (Allen and Fetterer, 2002).  Chemical anticoccidials generally control late 
stages of Eimeria development; for example, amprolium, which is chemically similar to 
thiamine, disrupts parasite development by blocking the transport of thiamine across the 
cell membrane (Chapman, 1993).  Ionophores are compounds that form lipid-soluble 
complexes with polar cations (K
+
, Na
+
, Ca²
+
, Mg²
+
) of biological importance (Pressman, 
1976). Monensin, which was introduced to the United States in 1971, is a carboxylic 
ionophore that behaves as an ―exchange diffusion‖ carrier of sodium, which may indirectly 
affect the intracellular concentration of calcium, inducing exocytotic release of secretory 
products from cells (Pressman, 1976; McDougald, 1990).  It was the first ionophore used 
in chickens and remains one of the most widely used ionophores today (McDougald, 1990; 
Chapman, 1993; Shirley et al., 2005).  During a coccidiosis infection, an ionophore will 
significantly disrupt ion balance in the sporozoite and cause severe cell damage, but the 
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trophozoite can also be affected (McDougald, 1990).  In 1983, Smith and Galloway 
examined the mechanism of monensin in extracellular sporozoites during an E. tenella 
infection and concluded that monensin resulted in a significant influx of sodium in to the 
sporozoite at a rate that exceeded the activity of the sodium potassium pump, leading to 
sodium accumulation in the cell.  The condition would eventually cause cells to swell from 
passive water influx, and then lyse (Leaf, 1970; Smith and Galloway, 1983).   
 Drug resistance to anticoccidials exists throughout the poultry industry and though 
the mechanisms of drug resistance have been studied, they are not yet fully understood 
(Jeffers, 1974; McDougald, 1981; Chapman, 1982; Williams, 2006).  Drug resistance to 
monensin has been acquired by Eimeria isolates dating back to the late 1970’s (Chapman, 
1982).  Chapman conducted several studies in the 70’s where field isolates of E. maxima, 
E. tenella, and E. acervulina from broiler and breeder farms were tested for sensitivity to 
monensin and found that monensin was significantly less effective against broiler isolates 
in reducing oocyst output and preventing weight loss (1976; 1979; 1982).  Investigators 
have postulated that Eimeria strains resistant to ionophores have sporozoites that exhibit 
decreased sodium uptake, possibly due to fundamental changes in the biophysical 
properties in the cell wall of the parasite specific to trans-membrane cation transport 
(Chapman, 1993).  Recently, investigators have explored the efficacy of using live, drug-
sensitive anticoccidial vaccines in combination with drugs in order to slow the resistance 
of local coccidia populations by alternating the two control methods and have found that 
sensitivity to prophylactics can be increased following administration of a live vaccine 
(Chapman, 1994; Stephan et al., 1997; Chapman et al., 2002).   
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Historically, many investigators believed that the use of prophylactic drugs could 
interfere with immune development to Eimeria, and when sulfonamides were first 
introduced in the 1940s, many studies were conducted to evaluate this relationship, which 
was reviewed by Chapman (2000).  The use of anticoccidial drugs may prevent sufficient 
numbers of the parasite from generating an immune response in the bird, preventing the 
bird from acquiring immunity, while vaccines should ensure the development of immunity 
(Chapman, 2000).  Furthermore, immunity development in the presence of anticoccidial 
drugs has been shown to take up to seven weeks, which is longer than most broilers are 
raised (Chapman, 1999; Chapman et al., 2004).  Because anticoccidial drugs must be 
withdrawn before slaughter, prevention of immune development creates a problem for 
producers in that birds may not have developed protective immunity before the 
anticoccidial is withdrawn, leaving the birds open to infection late in production.  The 
likelihood that new, effective drugs will be introduced in the future is low, so new methods 
of control must be investigated (Shirley, 1993).  
Coccidiosis Vaccination 
Recent research has been driven toward developing vaccines to provide a wider 
array of protection from Eimeria, though live vaccines have been available for over 50 
years (Shirley et al., 2005.  Vaccination is a viable means of controlling coccidiosis 
because of the strong protective immunity induced by the parasite against future infection 
by the same species (Yun et al., 2000; Williams, 2002; Mathis and Broussard, 2006; 
Williams, 2006).  Furthermore, live oocyst vaccination in broilers has resulted in 
performance equal to broilers fed anticoccidial drugs, which could provide an alternative to 
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drug use since resistance to traditional anticoccidial drugs is now widespread (Lee et al., 
2009).  Because Eimeria are highly immunogenic in chickens, live vaccines containing 
oocysts are the basis of coccidiosis vaccination (Chapman, 2000).  Vaccines that are 
genetically engineered, irradiated, or made from non-infective parasite derivatives are just 
a few examples of different vaccination strategies that have been investigated, but proven 
less effective at providing long lasting immunity compared to live oocyst vaccines (Rose 
and Hesketh, 1987; Danforth et al., 1989; Shirley, 1989).  After the vaccine is 
administered, immunity is stimulated by the development of the parasite, and then 
―boosted‖ by re-infection from the vaccine and from the resident Eimeria population in the 
poultry litter, but for protection to occur, auto re-infection from oocyst exposure is 
absolutely necessary (Chapman and Cherry, 1997; Chapman, 2000).  During the vaccine 
exposure, efficacy depends on the induction of both a humoral and cell mediated immune 
response (Yun et al., 2000).  Once these occur, immunity to the parasite will be permanent.   
 Non-attenuated vaccines are comprised of mixtures of wild-type strains of Eimeria 
where the numbers of oocysts are calculated so that when administered at the correct dose 
the vaccine is immunogenic but does not generate the a clinical coccidiosis infection 
(Chapman, 2000).   Non-attenuated vaccines, like Coccivac®-B, include wild-type strains 
of Eimeria (E. acervulina, E. maxima, E. mivati, and E. tenella) which immunize against 
all species present in the vaccine (Chapman, 2000; Intervet/Schering-Plough Animal 
Health/Merck and Co., Inc., Whitehouse Station, NJ).  Since immunity to Eimeria is 
species specific, it is necessary to include all species in a vaccine for complete protection.  
There is particular concern with live vaccines, produced with non-attenuated strains, that 
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the vaccine could introduce species into a poultry flock that are not currently present in the 
environment, but using limited species in vaccines could counter this problem (Chapman, 
2000; Williams, 2002).  Historically, coccidiosis vaccines have been used in breeder type 
birds, however, Coccivac®-B has been tailored for use in broiler chickens to induce 
immunity earlier since their life span is shorter (Williams, 2002).   
 Attenuated vaccines are comprised of strains that have been selected for reduced 
pathogenicity (Chapman, 2000).  Called ―precocious lines‖, attenuated strains have 
reproductive potentials less than their parent strain, making them less pathogenic (Shirley, 
1993).  Precocious lines of parasites have shortened endogenous cycles where generations 
of schizogeny are deleted or depleted (Jeffers, 1974).  The early stages of the life cycle are 
the most immunogenic, so they are present in the vaccine, but the deletion of endogenous 
cycles reduces pathogenicity for the host (Rose and Hesketh, 1976; Rose and Hesketh, 
1987).  These vaccines are not widely used in the United States.   
 Coccidiosis vaccines expose the host to low numbers of the parasite to stimulate 
protective immunity, but even light infections result in production losses (McDoulgald and 
Reid, 1997).  Because vaccination can cause production losses, commercial producers are 
hesitant to use them on a wide scale, compared to the use of in-feed anticoccidial drugs.  
Many studies have compared birds receiving vaccination to birds receiving anticoccidial 
drugs and found that vaccinated birds saw decreased body weight and poor feed 
conversion (Allen and Fetterer, 2002).  Other studies have demonstrated that vaccinated 
birds performed equally to medicated birds because once immunity was established the 
birds had a phase of compensatory gain (Lee et al., 2009).  Though these studies exist, 
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continued research is necessary find ways to improve broiler performance during 
coccidiosis infection.   
Probiotics 
Oral Tolerance  
The introduction of ―commensal‖ or normal bacterial flora to the gastrointestinal 
(GI) tract is critical to the development of the GALT.  Interactions between the gut 
microflora, the host GI tract, and the associated immune tissues are necessary for the 
complete and healthy development of the GI system (Dibner et al., 2008).  Abundant 
evidence dating back to the 1950’s indicates commensal microflora has a significant 
impact on the structure and function of the digestive tract (Coates, et al., 1955).  Through 
the study of germ-free animals, Coates and colleagues (1955) demonstrated that animals 
without commensal microflora had smaller gut sizes, including thinner intestinal villi and a 
thinner total gut wall, when compared to normally exposed animals.  During and 
immediately after parturition, or post hatch in chickens, exposure to non-pathogenic 
commensal bacteria occurs, then the gut is exposed to environmental antigens which 
stimulates the immune cells of the GALT (Pickard et al., 2004).  Gut colonization in chicks 
is rapid (Barrow et al., 1988).  Bar-Shira and colleagues (2002) described the events 
leading to GALT maturation in chickens occurring in this manner: the first wave happens 
after exposure to environmental antigens together with feed initially activates lymphocytes 
and natural killer (NK) cells residing mainly in the ―intraepithelial lymphocyte (IEL) 
compartment‖ of the newly hatched chicks.  Then, new T lymphocytes arrive in the lamina 
propria as it matures.  Commensal bacteria continue to play a role in protecting the host, 
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even after the GALT has developed.  The bacteria occupy ―niches‖ in the gut which 
provides protection from pathogenic bacteria (Janeway et al., 2001).  Nurmi and Rantala 
(1974) first described the theory of competitive exclusion as beneficial bacteria competing 
with foreign antigens for nutrients and attachment sites in the chicken small intestine.  The 
commensal bacteria also, in some cases, secrete soluble factors capable of inhibiting the 
growth and development of pathogens in the gut.  The benefits of ―good bacteria‖ during a 
coccidiosis infection have been well documented in poultry, and indicate that the use of 
probiotics could help ameliorate coccidiosis  (Dalloul et al., 2003; Awad, 2009).   
Probiotic Administration 
Because anticoccidial drugs are becoming less effective and coccidiosis vaccination 
is not widely used in broilers, investigators have begun exploring microbial supplements in 
an attempt to influence the host immune system (Dalloul et al., 2003; Lee et al., 2007).  
Probiotics are defined as live microbial supplements that when fed to an animal can confer 
a health benefit by improving intestinal microbial balance (Fuller, 1989).  The natural 
bacteria population in the intestine is capable of competitively excluding pathogens, and 
probiotics have been shown to facilitate these mechanisms (Dalloul and Lillehoj, 2005).  
The health and maintenance of the digestive tract is facilitated by the normal bacteria 
microflora present in the digestive tract, along with its gut associated lymphoid tissue, or 
―GALT‖ (Dalloul and Lillehoj, 2005).  Probiotics not only compete with foreign microbes 
for nutrients and attachment sites along the intestinal epithelium, but also probiotics secrete 
soluble factors that can inhibit the growth and efficacy of pathogens (Nurmi and Rantala, 
1973).   
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Probiotics have been used to stimulate the immune system in poultry, and, more 
recent, to modulate the immune stystem during an Eimeria infection (Dalloul et al., 2003; 
Farnell et al., 2006).  Probiotic supplementation has been shown ameliorate Eimeria 
infection by reducing oocyst shedding, increasing body weights, and increased secretion of 
Eimeria specific antibodies in broilers infected with E. acervulina and E. tenella (Dalloul 
et al., 2003; Lee et al., 2007).  Also, probiotics have been reported to prevent co-infections 
from opportunistic pathogens normally found in the gut because probiotics help maintain a 
healthy microbial balance (Dalloul and Lillehoj, 2005).  For example, probiotics could be 
especially helpful during an infection with E. maxima, which has been reported to promote 
necrotic enteritis when a host is suffering a co-infection with E. maxima and Clostridum 
perfringens (Park et al., 2008).   
Probiotics have also been shown to improve performance in broilers.  Eckert and 
colleagues (2010) administered a probiotic (Lactobacillus-based product also containing 
Enterococcus, Pediococcus and Bifidobacterium) intermittently via drinking water with 
and without monensin and found that birds not receiving monensin but receiving probiotic 
had increased growth compared to birds not receiving probiotic.  Other research has 
credited better performance seen in probiotic treated birds to increases in gut surface area, 
which enlarges the capacity for absorption of nutirents in the intestine.  Studies have 
shown that improved feed efficiency and body weight gain can correspond with increases 
in villus height and surface area in the small intestine (Samanya and Yamauchi, 2002; 
Awad et al., 2009).  In fact, longer villi not only indicate increased surface area for nutrient 
absorption, but also can be indicative of overall gut health because longer villi suggest 
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there is active cell mitosis and significant enterocyte turnover occurring (Samanya and 
Yamuchi, 2002; Yang et al., 2007).  Coccidiosis negatively effects nutrient absorption in 
the small intestine when the parasite creates lesions in the wall of the epithelium and 
causes epithelial cell sloughing.  The loss of these absorptive enterocytes impairs growth 
and feed utilization (Dalloul and Lillehoj, 2006).  If probiotics can increase digestive 
capacity in the intestine, perhaps they could offset some of the production losses from 
inhibited nutrient absorption during a coccidiosis infection.  
Dalloul and colleagues (2003; 2005) explored the efficacy of Lactobacillus-based 
in-feed probiotic on stimulating a local immune response to an infection with E. acervulina 
in an effort to identify some of the mechanisms involved in pathogen protection.  It was 
demonstrated that probiotic fed birds had a significant reduction in oocyst shedding 
following infection in two studies, indicating the probiotic fed birds were less susceptible 
to infection.  Also, observed increases in intestinal intraepithelial lymphocytes in probiotic 
fed birds were suspected to be the result of probiotic antigens nonspecifically stimulating 
the local immune system, which is supported by the well documented activity of T 
lymphocytes during a coccidiosis infection (Lillehoj and Trout, 1996).  In fact, 
investigators noted an increase in CD 4 and CD 8 cells in probiotic fed birds.  Probiotics 
also significantly up regulated the production of IFN-γ early during the E. acervulina 
infection, which has been shown to hinder intracellular parasite development (Lillehoj and 
Choi, 1998).   Chichlowski and colleagues (2007) demonstrated that feeding a 
heterogeneous probiotic (Lactobacillus casei, Lactobacillus acidophilus, Bifidobacterium 
thermophilum, and Enterococcus faecium) modified the innate intestinal immune response 
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by decreasing the level of  a proinflammatory cytokine (IL 6) and increasing the level of an 
antiinflammatory cytokines (IL 10) in the intestine.  The authors concluded that the 
probiotics had an antiinflammatory effect on the gut.   
Probiotics have also been shown to improve the physical barriers in the gut: 
intestinal epithelium.  Awad and colleagues (2009) investigated the effects of feeding a 
probiotic on the histomorphology of small intestinal mucosa using a probiotic product with 
Lactobacillus spp.   The authors found that probiotic increased the duodenal and ileal villus 
height and the villus height:crypt depth ratio, which was associated with increased body 
weights.  Sun and colleagues (2005) challenged birds with 3 species of Eimeria (E. 
maxima, E. acervulina, and E. tenella) and concurrently fed a probiotic containing 
Lactobacillus, Enterococcus, and Pediococcus.  Researchers measured lamina propria 
thickness and found that in probiotic treated birds the lamina propria was thinner compared 
to control birds, due to a lower pathogen load in the lower intestine; these data also 
corresponded with improved cumulative body weight gain.  Improving the gut architecture 
has multiple benefits.  It not only increases the ability of the chicken to resist pathogen 
invasion, but also it increase the functional capacity of the gut.  Greater functional capacity 
in the gut, indicated by increased surface area or length in the intestinal villi result in more 
enterocytes available for nutrient absorption.  
Conclusion 
 Currently, the poultry industry employs in-feed anticoccidial drugs and coccidiosis 
vaccinations; however, neither control method is without flaw.  The literature indicates that 
drug resistant Eimeria are widespread, and that future research and development on 
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anticoccidial drugs is unlikely.  The use of live oocyst vaccines confers protection from 
Eimeria, however, vaccines administration results in some production losses for producers 
(McDoulgald and Reid, 1997).  For a vaccine to fully protect against Eimeria, it must 
contain multiple species, and still the efficacy of the vaccine is questionable due to 
antigenic variations in strains and differences in resident Eimeria populations in different 
locations.  In previous research, probiotics have been shown to be viable means to 
improving bird performance during coccidiosis vaccination or challenge.  However, the 
ability of probiotics at mediating a coccidiosis infection and the interaction between 
probiotics and vaccination is still being explored.  If probiotics can improve the efficacy of 
coccidiosis vaccination or ionophores, probiotics could provide another tool for producers 
to combat coccidiosis.  Probiotics may improve gut morphology which could not only aid 
in pathogen resistance during an infection, but also could counteract the negative effects 
caused by Eimeria in the gut.  Also, research has evaluated how the immunomodulatroy 
effects of probiotics locally in the gut, but little research has explored how probiotics affect 
the systemic humoral status of the bird during a coccidiosis infection.  The goal of the 
present research was to investigate how current coccidia control methods, like ionophore 
application and vaccination, compare to and are affected by probiotic administration. 
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CHAPTER III 
INFLUENCE OF PROBIOTIC ADMINISTRATION, COCCIDIOSIS 
VACCINATION,  EIMERIA CHALLENGE, OR IONOPHORE 
ADMINISTRATION ON GUT MORPHOLOGY IN BROILERS 
Introduction 
 Coccidiosis is an intestinal disease of poultry caused by the protozoan 
parasite Eimeria (Williams, 1998).  The disease has a severe economic impact on the U.S. 
poultry industry (approximately $3 billion dollars annually) not only because of the cost of 
disease prevention and control (in-feed anticoccidial drugs and vaccinations), but also 
because of production losses from morbidity and mortality (Dalloul and Lillehoj, 2005).  
Eight species of Eimeria parasitize chickens, including: Eimeria acervulina, E. brunetti, E. 
maxima, E. mitis, E. mivati, E. necatrix, E. praecox, and E. tenella (Conway and 
McKenzie, 2007).  Each Eimeria species differs biologically, so controlling all Eimeria 
species with one control method is challenging and not always effective (Lillehoj, 1988; 
Lillehoj et al., 1989).  
Current Eimeria control methods include the use of different in-feed anticoccidial 
drugs, including ionophores.  Ionophores have been used in poultry feeds as a means of 
controlling coccidiosis infections for decades; however, drug resistance to ionophores in 
resident Eimeria populations is well documented (Jeffers, 1974; McDougald, 1981; 
Chapman, 1982; Williams, 2006).  Recent research has focused on developing vaccines to 
provide more protection from Eimeria (Williams, 2002; Mathis and Broussard, 2006; 
Williams, 2006).  Unfortunately, Eimeria vaccine administration results in some 
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production losses, so poultry producers are hesitant to use them (McDoulgald and Reid, 
1997).  As drug resistance becomes more widespread and reports of vaccine negatively 
affecting performance continue, researchers must explore new, economical ways to 
improve current Eimeria control methods for poultry producers.  
The natural bacterial population in the intestine is capable of competitively 
excluding pathogenic organisms, and probiotics have been shown to facilitate these 
mechanisms (Dalloul and Lillehoj, 2005).  A healthy digestive tract is maintained by the 
normal bacteria microflora present in the digestive tract, along with its gut associated 
lymphoid tissue (GALT) (Dalloul and Lillehoj, 2005).  Probiotics aid natural flora by 
competing with pathogens for nutrients and attachment sites along the gut epithelium, and 
by secreting soluble factors that can inhibit the growth of pathogens (Nurmi and Rantala, 
1973).  Probiotic supplementation has been shown to impact Eimeria infection by reducing 
oocyst shedding, increasing body weights, and increased secretion of Eimeria specific 
antibodies in broilers infected with E. acervulina and E. tenella (Dalloul et al., 2003; Lee 
et al., 2007).  Probiotics have also been shown to competitively exclude opportunistic 
pathogens known to co-infect chickens during Eimeria infections, like Clostridium 
perfringens (Park et al., 2008).  However, the interaction between probiotics and 
coccidiosis vaccination or ionophore application is still being investigated.   
Probiotics have also been shown to improve performance in broilers.  Eckert and 
colleagues (2010) administered a probiotic (Lactobacillus-based product also containing 
Enterococcus, Pediococcus and Bifidobacterium) intermittently via drinking water and 
found that receiving probiotic had increased growth compared to birds not receiving 
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probiotic.  Other research has shown that improved feed efficiency and body weight gain 
can correspond with increases in villus height and surface area in the small intestine, which 
is due to increased digestive and absorptive capacity in the gut (Samanya and Yamauchi, 
2002; Awad et al., 2009).  Longer villi indicate increased surface area for nutrient 
absorption and can also be indicative of overall gut health because longer villi signify there 
is active cell mitosis occurring (Samanya and Yamuchi, 2002; Yang et al., 2007).  
Increased lamina propria thickness indicates an influx of immune cells to the intestinal 
mucosa, which previous research has associated with increased pathogen resistance (Tellez 
et al., 1993).  Crypt depth and villus height to crypt depth ratio are both associated with 
enterocyte regeneration and proliferation, as well as the functional capacity of the villi 
(Hampson, 1986; Solis de los Santos et al., 2005; Yang et al., 2007).  Coccidiosis inhibits 
nutrient absorption in the small intestine because the parasite creates lesions in the wall of 
the epithelium and causes epithelial cell sloughing; subsequently impairing feed utilization 
and growth (Dalloul and Lillehoj, 2005).  Probiotics have the potential to benefit gut 
morphology, which could aid in resisting pathogens, Eimeria as well as opportunistic 
pathogens, and increase the absorptive capacity of the intestinal villi.  Increasing the 
digestive and absorptive capacity of the small intestine during a coccidiosis infection could 
help offset malabsorption and weight loss caused by the parasite, which would benefit the 
poultry producer.  We hypothesized that probiotics would benefit gut morphology by 
increasing surface area in the intestine.  Our objective was to evaluate the effects of 
administering probiotics compared to and when administered with coccidiosis vaccination 
and ionophore treatement by measuring changes in gut morphology (villus height, villus 
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width, villus surface area, crypt depth, villus height to crypt depth ratio and lamina propria 
thickness). 
Materials and Methods 
Birds and Experimental Design 
 On day-of-hatch, Cobb 500 male chickens were obtained from a local commercial 
hatchery, placed into floor pens with 50% fresh pine shavings and 50% built up litter, and 
provided supplemental heat to simulate industry rearing conditions.  The birds were 
provided water via a nipple drinker system, which also dispensed the probiotic, and were 
fed a diet shown to enhance performance of birds administered a coccidiosis vaccination 
using the following feeding program: starter phase (D1-15), grower phase (D15-29), 
finisher phase (D29-32) and withdrawal phase (D33-42) (Lee et al., 2009).  The ionophore 
and challenge (below) were administered via the feed.  The experiment was conducted in a 
broiler rearing facility at the Texas A&M University Poultry Science Teaching, Research, 
and Extension Center, and animal care and husbandry were provided according to an 
approved Texas A&M Institutional Animal Care and Use protocol.   
 The experimental design used a 3x2 factorial ANOVA design with 3 coccidia 
control methods (control, ionophore and coccidiosis vaccination) and 2 probiotic groups 
(probiotic and no probiotic) to determine how the administration of probiotic and coccidia 
control methods affect avian gut morphology.  Individual treatment groups were negative 
control, probiotic only, vaccination only, vaccination with probiotic, ionophore only, and 
ionophore with probiotic.     
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Eimeria Challenge 
Field strain Eimeria oocysts derived from a local broiler production facility was 
used to challenge the birds.  Species present included: E. acervulina, E. mivati, E. maxima, 
and E. tenella.  Feed challenges were administered on day 14 (50,000 oocysts per bird) and 
on day 36 (750,000 oocysts per bird).  
Probiotic Administration 
A commercially available probiotic (Poultry Star
®
, Biomin, GmbH,
 
Herzogenburg, 
Austria) was administered at a concentration in accordance with the manufacturer’s 
recommendations (20 grams per 1,000 broilers) to the appropriate treatment pens in 
drinking water by utilizing an independent watering system.  Species present in the 
probiotic were Enterococcus faecium, Pediococcus acidilactici, Bifidobacterium animalis, 
and Lactobacillus reuteri.  Probiotic was administered intermittently from day of 
placement through day 2, from days 9-10, 13-15, 25-27, and 32-34, which correspond with 
each feed change.     
Ionophore Administration 
The ionophore monensin (Coban-90, Elanco Animal Health, Indianapolis, IN) was 
added to the feed per manufacturer’s recommendations (90 grams per ton) according to the 
treatment group.  On day 33 the ionophore was removed from the feed to create a 
withdrawal ration to simulate industry methods.   
Vaccination 
Vaccinated birds received Coccivac®-B (Intervet/Schering-Plough Animal 
Health/Merck and Co., Inc., Whitehouse Station, NJ), a non-attenuated live oocyst 
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coccidiosis vaccine for use in broiler chickens.  The vaccine was applied using a 
Spraycox
®
 II cabinet (Intervet/Schering-Plough Animal Health/Merck and Co., Inc., 
Whitehouse Station, NJ).  Before placement, the birds were allowed to preen for an hour 
under bright light.   
Histological Sampling  
On days 6, 22, 36, and 43, a 2-3 cM sample was excised from the midpoint of the 
duodenum and lower ileum from each broiler and flushed with ice cold saline.  The 
samples were stored in 50 mL of 10% neutral buffered formalin in a plastic tissue sample 
container.  The samples were prepared for morphological evaluation by cutting 
approximately 2-3 mM of each sample with a razor blade and placing the tissue in a tissue 
cassette for future tissue embedding.  The sample cassettes were labeled per section of 
intestine, day and treatment group, then stored in 10% neutral buffered formalin and 
shipped to a commercial service laboratory (Histo-Scientific Research Laboratory, Mount 
Jackson, VA) for tissue embedding, slide fixing and hemotoxylin and eosin staining.     
Morphological Measurements 
Sample slides were scanned into the Adobe Photoshop CS4 Extended program 
(Adobe, San Jose, CA) using an Epson Perfection 4990 Photo (Epson America, Inc., Long 
Beach, CA) scanner at 4800 dpi (pixels per inch) on a fixed scale.  In Photoshop, the 
measurement tool was used to measure the number of pixels to determine the height and 
width of the villi, the depths of the crypts and the thickness of the lamina propria tissue.  
The pixels were converted to millimeters (mM) using the dpi from the original scan.  The 
measurements from Adobe were entered into Microsoft Excel (Microsoft Office 
 37 
Proffessional 2007, Redmond, WA) and a formula was used to calculate surface area 
(mM
2
) and villus height to crypt depth ratio. 
Each section on a slide represented 1 bird, and 5 measurements were recorded per 
bird in each group. The replicate measurements for each bird were averaged to yield a 
mean villus height and width (used to calculate mean surface area), mean crypt depth, 
(used to calculate mean villus height to crypt depth ratio) and lamina propria thickness for 
each bird.  Villus height was measured from the top of the villus to the top of the lamina 
propria (Solis de los Santos et al., 2005).  Villus width was measured at the base of the 
villus (Solis de los Santos et al., 2005).  Surface area was calculated using the formula: 
(2Π)*(villus width/2)*(villus height) (Sakamoto et al., 2000; Solis de los Santos et al., 
2005).  Crypt depth was measured from the base of the villus upward to the region of 
transition between the crypt and villus.  The crypt is defined as the depth of invagination 
between adjacent villi.  Villus height to crypt depth ratio was calculated by dividing each 
bird’s villus height by its crypt depth (Aptekmann et al., 2001; Solis de los Santos et al., 
2005; Awad et al., 2009).  Lamina propria thickness was measured from the basement 
membrane of the epithelium to the muscularis mucosa (Sun et al., 2005). 
Statistical Analysis 
 Data were measured using a factorial ANOVA and main effect means were deemed 
significant at P ≤ 0.05.  In cases where significant interactions were observed, data was 
subjected to a one-way ANOVA.  All means were separated using a Duncan’s Multiple 
Range Test.  Statistical analysis was completed with the SPSS statistical software package 
(Chicago, IL).   
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Results 
Duodenum 
 On day 6, no significant differences were observed in intestinal crypt depth (Table 
3-1).  The main effect means in villus height to crypt depth ratio were significantly 
different.  Control and vaccinated birds had a significantly higher ratio compared to 
medicated birds, and there was no significant difference in probiotic and non probiotic 
birds (Table 3-2).  There were significant interactions observed in the duodenum in villus 
height, width, surface area and lamina propria thickness (Table 3-3, 3-4, 3-5, and 3-6).  
The vaccinated only group had significantly longer villi, while the vaccine with probiotic 
group had significantly shorter villi compared to the control and probiotic only group 
(Table 3-3).  The ionophore only and ionophore with probiotic groups also had 
significantly shorter villi compared to the control and probiotic only group.  The 
vaccinated only, probiotic only and control birds had significantly wider villi and greater 
surface area than the vaccine with probiotic, ionophore only, and ionophore with probiotic 
birds (Table 3-4 and 3-5).  The probiotic only and vaccinated only birds had the thickest 
lamina propria (Table 3-6).  Control birds had signigicantly thicker lamina propria than the 
ionophore with probiotic birds, but not the vaccine with probiotic or medicated only birds.   
 On day 22, there were no significant differences in main effect means in villus 
height to crypt depth ratio.  Vaccinated and medicated birds had significantly deeper crypts 
compared to control birds, while there was no difference in probiotic versus non probiotic 
birds (Table 3-1).  Vaccinated birds had significantly thicker lamina propria compared to 
control and medicated birds, and there was no difference in probiotic versus non probiotic 
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Table 3-1.  Villus crypt depth (mM) in the duodenum and lower ileum for all experimental 
groups on each sample collection day.    
Treatment  Duodenum Lower Ileum 
Control 
Measure Probiotic Day 6 Day 22 Day 36 Day 43 Day 6 Day 22 Day 36 Day 43 
Control  Control 0.10 0.16 0.28 0.44a 0.06 0.16 0.19a 0.22 
Control Probiotic 0.10 0.17 0.29 0.35b 0.06 0.15 0.17bc 0.24 
Vaccine Control 0.11 0.19 0.30 0.31bc 0.08 0.17 0.15c 0.23 
Vaccine Probiotic 0.09 0.20 0.30 0.32bc 0.07 0.16 0.19ab 0.23 
Ionophore Control 0.09 0.20 0.28 0.26c 0.07 0.18 0.21a 0.23 
Ionophore Probiotic 0.10 0.21 0.30 0.34b 0.07 0.17 0.20a 0.25 
                    
Main Effects                   
Control   0.10 0.16b 0.29 0.40 0.06c 0.15c 0.18 0.23 
Vaccine   0.10 0.19a 0.30 0.31 0.07a 0.16ab 0.18 0.23 
Ionophore   0.09 0.20a 0.29 0.29 0.07b 0.17a 0.21 0.24 
                    
  Probiotic 0.10 0.19 0.30 0.34 0.07 0.16 0.19 0.24 
  Non Probiotic 0.10 0.18 0.29 0.34 0.07 0.17 0.19 0.23 
     a-c
 Means of individual experimental groups with different subscripts differ significantly at P ≤ 0.05 
      a-c 
Means of main effects with different subscripts differ significantly at P ≤ 0.05 
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Table 3-2.   Villus height to crypt depth ratio in the duodenum and lower ileum for all 
experimental groups on each sample collection day.     
Treatment  Duodenum Lower Ileum 
Control 
Measure Probiotic Day 6 Day 22 Day 36 Day 43 Day 6 Day 22 Day 36 Day 43 
Control  Control 9.52 12.73 9.16 5.59 7.52 5.54 5.24 5.03 
Control Probiotic 11.29 11.41 8.28 5.93 8.22 6.32 5.84 4.34 
Vaccine Control 10.55 9.91 7.77 7.05 5.75 4.97 5.67 4.52 
Vaccine Probiotic 10.54 10.97 7.99 7.48 6.07 5.48 4.64 5.15 
Ionophore Control 8.09 12.04 7.32 7.79 6.56 5.16 4.90 4.01 
Ionophore Probiotic 7.49 11.53 6.82 5.09 5.92 5.48 4.71 3.53 
                    
Main Effects                   
Control   10.22a 12.07 8.72a 5.75b 7.85a 5.91 5.54 4.68a 
Vaccine   10.54a 10.44 7.87ab 7.27a 5.91b 5.24 5.19 4.81a 
Ionophore   7.73b 11.75 7.07b 6.74ab 6.23b 5.31 4.81 3.80b 
                    
  Probiotic 9.24 11.30 7.68 6.32 6.68 5.76 5.10 4.34 
  Non Probiotic 9.40 11.52 8.08 6.80 6.63 5.25 5.27 4.52 
         a,b Means of main effects with different subscripts differ significantly at P ≤ 0.05 
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Table 3-3.  Villus height (mM) in the duodenum and lower ileum for all experimental 
groups on each sample collection day. 
Treatment  Duodenum Lower Ileum 
Control 
Measure Probiotic Day 6 Day  22 Day  36 Day  43 Day 6 Day 22 Day 36 Day 43 
Control  Control 0.93b 2.03bc 2.48a 2.40 0.47 0.86 1.03 1.09 
Control Probiotic 1.08ab 1.84bc 2.39a 2.11 0.52 0.96 0.97 1.03 
Vaccine Control 1.17a 1.81c 2.26ab 2.13 0.44 0.82 0.89 1.02 
Vaccine Probiotic 0.73c 2.12ab 2.36a 2.35 0.44 0.89 0.87 1.09 
Ionophore Control 0.70c 2.36a 2.03b 1.93 0.44 0.94 1.03 0.94 
Ionophore Probiotic 0.70c 2.39a 2.00b 1.77 0.42 0.93 0.95 0.86 
                    
Main Effects                   
Control   0.99 1.94 2.44 2.25a 0.48a 0.91 .99a 1.06a 
Vaccine   1.01 1.97 2.32 2.24a 0.44ab 0.86 .99a 1.04a 
Ionophore   0.71 2.38 2.02 1.86b 0.42b 0.93 .87b .89b 
                    
  Probiotic 0.82 2.12 2.25 2.10 0.46 0.93 0.93 0.98 
  Non Probiotic 0.93 2.04 2.26 2.15 0.45 0.88 0.98 1.01 
 a-c
 Means of individual experimental groups with different subscripts differ significantly at P ≤ 0.05 
 a,b 
Means of main effects with different subscripts differ significantly at P ≤ 0.05 
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Table 3-4.  Villus width (mM) in the duodenum and lower ileum for all experimental 
groups on each sample collection day. 
 Treatment  Duodenum Lower Ileum 
Control Measure Probiotic Day  6  Day 22 Day 36 Day 43 Day 6 Day 22 Day 36 Day 43 
Control  Control 0.13a 0.27a 0.35 0.44 0.16 0.29 0.23 0.26 
Control Probiotic 0.14a 0.26a 0.36 0.45 0.16 0.29 0.27 0.26 
Vaccine Control 0.13a 0.25ab 0.35 0.35 0.13 0.25 0.26 0.23 
Vaccine Probiotic 0.10b 0.26a 0.39 0.36 0.17 0.22 0.24 0.27 
Ionophore Control 0.09b 0.26a 0.36 0.29 0.14 0.19 0.29 0.24 
Ionophore Probiotic 0.10b 0.21b 0.37 0.41 0.17 0.19 0.26 0.24 
                    
Main Effects                   
Control   0.14 0.27 0.35 0.44a 0.16 0.29a 0.25 0.26 
Vaccine   0.13 0.26 0.37 0.35b 0.15 0.23b 0.25 0.25 
Ionophore   0.10 0.24 0.36 0.34b 0.15 0.19c 0.27 0.24 
                    
  Probiotic 0.12 0.25 0.37 0.41 0.17 0.23 0.26 0.26 
  Non Probiotic 0.12 0.26 0.35 0.36 0.14 0.25 0.26 0.24 
        a,b
 Means of individual experimental groups with different subscripts differ significantly at P ≤ 0.05 
        a-c 
Means of main effects with different subscripts differ significantly at P ≤ 0.05 
 
 
 
 
 
 
 
 43 
Table 3-5.   Villus surface area (mM
2
) in the duodenum and lower ileum for all 
experimental groups on each sample collection day. 
Treatment  Duodenum Lower Ileum 
Control 
Measure Probiotic Day 6 Day 22 Day 36 Day 43 Day 6 Day 22 Day 36 Day 43 
Control  Control 0.41a 1.76ab 2.72 3.32 0.24 0.80 0.75 0.90 
Control Probiotic 0.48a 1.53b 2.67 3.01 0.26 0.88 0.80 0.86 
Vaccine Control 0.45a 1.43b 2.49 2.33 0.19 0.65 0.72 0.75 
Vaccine Probiotic 0.24b 1.75ab 2.92 2.54 0.24 0.62 0.64 0.88 
Ionophore Control 0.21b 1.96a 2.32 1.81 0.18 0.56 0.93 0.70 
Ionophore Probiotic 0.23b 1.64ab 2.35 2.32 0.22 0.53 0.78 0.65 
                    
Main Effects                   
Control   0.44 1.65 2.70 3.17a 0.24a 0.83a 0.77a 0.87a 
Vaccine   0.37 1.60 2.70 2.43b 0.21ab 0.63b 0.68b 0.81a 
Ionophore   0.22 1.79 2.34 2.02b 0.20 b 0.54b 0.67b 0.67b 
                    
  Probiotic 0.31 1.64 2.65 2.63 0.24 0.68 0.74 0.80 
  Non Probiotic 0.35 1.70 2.51 2.49 0.20 0.67 0.80 0.79 
      a,b
 Means of individual experimental groups with different subscripts differ significantly at P ≤ 0.05 
          a,b Means of main effects with different subscripts differ significantly at P ≤ 0.05 
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Table 3-6.   Lamina propria thickness (mM) in the duodenum and lower ileum for all 
experimental groups on each sample collection day. 
Treatment  Duodenum Lower Ileum 
Control 
Measure Probiotic Day 6 Day 22 Day 36 Day 43 Day 6 Day 22 Day 36 Day 43 
Control  Control 0.13b 0.28 0.35 0.33 0.15 0.23 0.23 0.27 
Control Probiotic 0.17a 0.24 0.34 0.39 0.15 0.22 0.25 0.27 
Vaccine Control 0.18a 0.33 0.31 0.35 0.16 0.23 0.22 0.23 
Vaccine Probiotic 0.12bc 0.33 0.32 0.35 0.16 0.21 0.22 0.27 
Ionophore Control 0.12bc 0.27 0.38 0.38 0.17 0.23 0.25 0.23 
Ionophore Probiotic 0.10c 0.23 0.36 0.36 0.16 0.25 0.23 0.25 
                    
Main Effects                   
Control   0.15 0.26b 0.34ab 0.36 0.14b 0.22 0.23ab 0.26a 
Vaccine   0.16 0.32a 0.31b 0.35 0.16ab 0.22 0.21b 0.24ab 
Ionophore   0.12 0.25b 0.37a 0.37 0.16a 0.24 0.24a 0.24b 
                    
  Probiotic 0.14 0.27 0.34 0.37 0.16 0.22 0.23 0.26a 
  Non Probiotic 0.15 0.29 0.35 0.36 0.16 0.23 0.23 0.24b 
       a-c
 Means of individual experimental groups with different subscripts differ significantly at P ≤ 0.05 
       a,b 
Means of main effects with different subscripts differ significantly at P ≤ 0.05 
 
birds (Table 3-6).  There were significant interactions observed in villus height, width and 
surface area.  The ionophore only and ionophore with probiotic birds had significantly 
longer villi than the vaccinated only, control and probiotic only birds (Table 3-3).  The 
vaccine with probiotic birds had significantly longer villi than the vaccinated only birds.  
The ionophore with probiotic group had significantly thinner villi compared to all other 
groups except the vaccinated only group, which was not significantly different from any 
group (Table 3-4).  Medicated only birds had significantly greater surface area compared to 
the vaccinated only and probiotic only birds (Table 3-5).   
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 On day 36, significant interactions were only observed in villus height, and there 
were no significant differences observed in main effect means in villus width, surface area, 
or crypt depth.  Control birds had significantly increased villus height to crypt depth ratio 
compared to ionophore treated birds and there was no difference in probiotic 
administration (Table 3-2).  Ionophore treated birds had significantly thicker lamina 
propria compared to vaccinated birds and there was no difference in probiotic 
administration (Table 3-6).  There was a significant interaction between probiotic 
administration and control method in regard to villus height (Table 3-3).  The vaccine with 
probiotic, probiotic only, and control groups had significantly longer villi compared to the 
medicated only and ionophore with probiotic group.   
 On day 43, there were no significant differences in lamina propria thickness.  
Ionophore treated birds had significantly shorter villi compared to the vaccinated and 
control birds (Table 3-3).  The control birds had significantly wider villi, greater surface 
area, and deeper crypts than vaccinated and medicated birds, while vaccinated birds had a 
significantly higher villus height to crypt depth ratio than control birds (Table 3-4, 3-5, and 
3-1).  No differences were observed with regard to probiotic administration.   
Lower Ileum  
 On day 6, control birds had significantly longer villi, greater surface area, and 
higher ratio than medicated birds, but not vaccinated birds (Table 3-3, 3-5, and 3-2).  There 
were no significant differences in villus width.  Vaccinated birds had significantly deeper 
crypts compared to the ionophore treated and control birds, while control birds had the 
shallowest crypts (Table 3-1).  The ionophore fed birds had significantly thicker lamina 
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propria compared to the control birds, while vaccinated birds were intermediate (Table 3-
6).  There were no observed differences in probiotic administration for any measurement.  
 On day 22, significant differences were observed in main effect means in villus 
width, surface area, and crypt depth.  Control birds had significantly wider villi than 
ionophore and vaccinated birds, and ionophore birds had significantly thinner villi than 
vaccinated and control birds (Table 3-4).  Control birds had significantly greater surface 
area compared to vaccinated and ionophore treated birds (Table 3-5).  Ionophore birds had 
significantly deeper crypts compared to control birds (Table 3-4).  There were no 
significant differences in probiotic administration for any measurement.  
 On day 36, there was a significant interaction in crypt depth, and significant 
differences in main effect means in villus height and surface area.  Control and vaccinated 
birds had significantly longer villi compared to ionophore birds (Table 3-3).  Ionophore 
treated birds had significantly greater surface area compared to vaccinated birds, and 
significantly increased lamina propria thickness compared to vaccinated birds (Table 3-5 
and 3-6).  There were no observed differences in probiotic administration.  There was an 
observed interaction between the control measure and probiotic administration, with the 
probiotic group having significantly deeper crypts than the vaccinated only group (Table 3-
1).  The control, ionophore, and ionophore with probiotic group had significantly deeper 
crypts than the probiotic only, vaccine only and vaccine with probiotic groups.   
On day 43, differences in main effect means were observed in villus height, surface area, 
ratio, and lamina propria thickness.  Control and vaccinated birds had significantly longer 
villi, greater surface area, and deeper crypts compared to ionophore treated birds (Table 3-
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3, 3-5, and 3-1).  Control birds also had significantly thicker lamina propria compared to 
ionophore treated birds (Table 3-6).  Non probiotic birds had significantly longer villi 
compared to probiotic birds (Table 3-3).   
Discussion 
Vaccine and Probiotic Interactions   
 The addition of probiotics to the vaccine caused several significant interactions in 
the duodenum on days 6 and 22, which corresponded to timepoints before and after the 
first feed challenge on day 14.  On day 6, the vaccine with probiotic group had 
significantly decreased villus height, villus width, villus surface area, and lamina propria 
thickness compared to the vaccinated only birds.  Probiotics adhere to the intestinal 
mucosa, preventing pathogens from binding to epithelial receptors in the intestine and 
limiting exposure (Koenan et al., 2002).  These data suggest that the probiotic, when added 
to the vaccine, may have prevented cell damage caused by the invasion of Eimeria; 
however, the probiotic may not have been able to prevent the destruction of all the 
enterocytes, which could explain why there was some decreases in villus integrity.  In one 
study, Dalloul and colleagues found (2005) that during an Eimeria challenge splenic 
lymphocytes from non probiotic birds secreted more IFNγ when compared to probiotic fed 
birds and concluded that the probiotic may enhance the mucosal immune response and 
provide better local protection from infection when compared to non probiotic fed birds.  
These data may suggest that probiotics given with a coccidiosis vaccination delays the 
onset of activity by systemic immune cells.  Mayer (1997) reported that the mucosal 
immune system can have an immunosuppressive effect on the systemic immune system, 
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though the mechanism is not fully understood.  Since probiotics have been shown to 
modulate the mucosal immune system, they could contribute to the suppression of the 
systemic immune system.  When comparing vaccinated birds to ionophore treated birds on 
day 6, vaccinated birds had a significantly higher villus height to crypt depth ratio, though 
there was no difference in probiotic administration.  Increased villus height to crypt depth 
ratios have been associated with improved performance, while shallow crypts can be an 
indicator of low enterocyte turnover; therefore, these data could suggest that the vaccinated 
birds had less cell damage resulting from parasite infection, and did not need to 
compensate for decreased numbers of enterocytes (Yang et al., 2007; Awad et al., 2009).  
This result does not indicate a decrease in performance, since in the vaccinated only group, 
measurements of villus height, villus width and villus surface area were still significantly 
better than both ionophore treated groups, and comparable to the control birds.  These 
birds should have had increased functional capacity of their villi for absorption of nutrients 
from the lumen (Aptekmann et al., 2001).  In the lower ileum, probiotic administration had 
no effect on intestinal morphology on day 6, and morphology in vaccinated birds was not 
significantly different from control birds except in crypt depth and ratio.  Vaccinated birds 
had significantly deeper crypts and lower villus height to crypt depth ratio, which indicates 
that there could have been increased enterocyte proliferation and generation, though this 
did not increase villus height, villus width, or villus surface area.  These data could 
indicate that there was some cell damage occurring in the vaccinated groups compared to 
the control groups, and perhaps the enterocytes are compensating for cell damage by 
regenerating cells that had been damaged by the parasite (Ruff and Wilkins, 1980; Yun et 
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al., 2000).  Also, these data suggest that the vaccinated birds are being affected differently 
by the vaccine in lower ileum versus the duodenum, possibly due to the Eimeria species 
localized in each section of the intestine.  In the lower ileum, E. tenella can cause severe 
cell damage, which could explain why there is increased enterocyte generation in the lower 
ileum compared to the duodenum in the vaccinated birds. 
After the day 14 feed challenge, the addition of probiotic to the vaccine 
significantly increased villus height in the duodenum, and vaccinated birds had 
significantly increased lamina propria thickness compared to medicated and control birds.  
The increase in villus height supports that in response to a pathogen, probiotics could 
benefit villus morphology (Awad et al, 2006).   In the lower ileum, vaccinated birds had 
significantly decreased surface area and increased crypt depth compared to the control 
birds post-challenge.  Reduced villus integrity indicates damage from a pathogen, and the 
decrease in morphology seen here could be associated with second peak cycling from the 
vaccine (Dunsford et al., 1989).        
Ionophore 
 Ionophore birds had significantly decreased villus height and surface area 
compared to control birds on day 6 in the duodenum and lower ileum; also, in the lower 
ileum decreased surface area and increased crypt depth  was observed in ionophore treated 
birds compared to the control birds after the day 14 feed challenge, but in the duodenum 
the ionophore only birds had significantly longer villi than the control birds and greater 
surface area than the vaccinated birds.  There was significantly decreased villus height at 
day 36 and 43 in the duodenum and at day 43 in the ileum, with a corresponding increase 
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in lamina propria thickness at day 36 in the duodenum.  These observations suggest that 
the ionophore could have been protecting the birds from the Eimeria until the monensin 
was removed from the feed on day 33.  Increased lamina propria thickness could indicate 
that there was an influx of immune cells into the tissue by day 43 due to the ionophore 
removal and day 36 feed challenge, while the decreased villus height could have been 
caused by the destruction of enterocytes by the parasite (Tellez et al, 1993; Dunsford et al., 
1989).  These data support that the use of ionophore in the feed delayed exposure to the 
parasite until the ionophore was removed, leaving the birds open to infection late in 
production.  Also, poor villus integrity in ionophore birds demonstrated throughout the 
experiment suggests that while the ionophore may have been protecting the birds from the 
lower level day 14 exposure in the duodenum, enterocyte destruction was still occurring in 
the lower ileum.  The ionophore may have prevented the birds from generating protective 
immunity to the Eimeria, which explains why after the removal of the ionophore on day 
33, lamina propria tissue in the duodenum and lower ileum significantly increased 
compared to vaccinated birds.  Ionophore birds also had a decreased ratio compared to 
control birds on day 36, which suggests that the ionophore birds had increased enterocyte 
regeneration, possibly in compensation for the cell damage that was occurring as a result of 
the delayed infection (Ruff and Wilkins, 1980). 
Probiotic 
 In the lower ileum on day 43, probiotic birds had thicker lamina propria compared 
to non probiotic birds.  These data suggest that probiotic birds had increased immune cell 
activity in the mucosa late during production.      
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Conclusions 
The data demonstrate that feeding of probiotics, coccidiastats, and coccidia 
vaccination influence gut morphology and maturation.  At select timepoints the addition of 
probiotic to a control method improved gut morphology by increasing villus height or 
surface area, which indicates that those birds had improved digestive and absorptive 
capacity.  Furthermore, there were instances in both the vaccinated and ionophore groups 
where the gut demonstrated what could have been compensatory cell production in 
response to cell damage from the Eimeria, however, in the ionophore treated birds this 
occurred in the last phase of production, indicating decreased functional capacity.  Further 
investigation is necessary to evaluate the compensatory mechanisms of the intestine in 
response to a coccidiosis infection, and to evaluate if ionophores negatively affect gut 
morphology.  More research is needed to evaluate the interaction of probiotics and 
coccidiosis vaccination, since the addition of probiotic to the vaccine did not always 
produce the same result.  If probiotics could be used to improve the activity of coccidiosis 
vaccines by achieving immunity earlier, or ameliorating production losses caused by 
vaccine administration, that knowledge could be used to benefit poultry producers.     
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CHAPTER IV 
INFLUENCE OF PROBIOTIC ADMINISTRATION, COCCIDIOSIS 
VACCINATION,  EIMERIA CHALLENGE, OR IONOPHORE 
ADMINISTRATION ON BROILER IgG SECRETION 
Introduction 
The intestinal disease coccidiosis is economically burdensome to the commercial 
poultry industry, with the costs of the disease per annum totaling 3 billion U.S. dollars 
(Dalloul and Lillehoj, 2006).  Eight species of Eimeria have been identified to parasitize 
chickens, such as: Eimeria acervulina, E. brunetti, E. maxima, E. mitis, E. mivati, E. 
necatrix, E. praecox, and E. tenella (Chapman 2000; Conway and McKenzie, 2007).  
Because each Eimeria species is immunogenically unique, a challenge exists to control all 
species with a single method (Lillehoj, 1989).  
Current Eimeria control methods include the use of in-feed anticoccidial drugs, like 
ionophores, however, drug resistance to ionophores is now widespread (Jeffers, 1974; 
McDougald, 1981; Chapman, 1982; Williams, 2006).  Recent research has focused on 
developing vaccines to provide more protection against Eimeria (Williams, 2002; Mathis 
and Broussard, 2006; Williams, 2006).  Poultry producers are hesitant to use coccidiosis 
vaccines because of the production losses incurred during immunity development in 
response to the vaccine.  Many studies have compared birds receiving vaccination to birds 
receiving anticoccidial drugs and found that vaccinated birds saw decreased body weight 
and poor feed conversion (Allen and Fetterer, 2002).  As resistance to anticoccidial drugs 
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and the reluctance to use vaccines continue, new methods to improve coccidiosis control 
must be investigated further.    
Upon exposure to Eimeria, chickens produce IgM, IgA, and chicken IgG (Dalloul 
and Lillehoj, 2005).  Chicken IgG is concentrated in the yolk sac of the egg and is 
transported to the embryo late during development, and these maternal antibodies have 
been reported to provide some passive immunity to Eimeria (Lillehoj, 1987; Lillehoj et al., 
2004).  Rose and Long (1971) explored the protective effects of transferring immunity to 
chick embryos.  The authors found that antibodies provided protection from E. tenella 
infection only when the ―donors‖ (hens) were actively developing immunity to E. tenella 
(Rose and Long, 1971).  Though the investigators felt that the result of maternal 
transmission of protection to embryos was inconclusive due to testing methods used at the 
time, they did note oocyst output reduction in the progeny of immunized hens when chicks 
were challenged at 4 days of age with E. tenella oocysts (Rose and Long, 1971).   
In the 1990s, several investigators (Wallach et al., 1992; Smith et al., 1994a; Smith 
et al., 1994b; Wallach et al., 1995) reported that although maternal immunity to E. maxima 
infections decreased gradually over time, which was show in decreased IgG titers in egg 
yolk and chick sera, maternal antibodies still play a significant role in protecting the chick 
at the time of hatch.  Parasite specific IgG could be transferred to chicks in the yolk, and 
protect against infection for the first 2-3 weeks outside of the egg (Rose and Long, 1971; 
Rose, 1972).  Early protection against infection could be beneficial, especially in broilers, 
because immunizing one breeder hen could provide protection to numerous broiler chicks 
(Smith et al., 1994b).  Also, though maternal immunity is considered almost non-existent 
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by 3 weeks of age, Smith and colleagues (1994b) asserted that these chicks would be 
protected long enough to prevent severe coccidiosis before slaughter.  Investigators also 
found that oocyst output in hatchlings that were progeny of immunized breeding hens was 
reduced after a challenge with E. maxima oocysts (Smith et al., 1994a; Wallach et al., 
1995).  Wallach and colleagues (1995) also determined that chicks immunized with 
affinity purified gametocyte antigens from Eimeria maxima were not only immunized to 
Eimeria maxima, but also partially immunized to infections with E. tenella and E. 
acervulina.  These parasite specific maternal antibodies serve a role in humoral immunity 
by reducing infectivity as a consequence of parasite neutralization, and the ability to 
modulate these antibodies would provide a means of decreasing the invasive potential of 
Eimerai (Lillehoj and Lillehoj, 2000).   
The natural microflora present in the gut is capable of competitively excluding 
pathogenic organisms and facilitating gut health (Dalloul and Lillehoj, 2005).  Previous 
studies have shown that probiotics can prevent disease by competing with pathogens for 
nutrients and attachment sites along the intestinal epithelium, but also probiotics secrete 
soluble factors that can inhibit the growth and efficacy of pathogens (Nurmi and Rantala, 
1973; Koenen, 2004).  Probiotics were reported to protect against bacterial pathogens, but 
recently have been shown to protect poultry from Eimeria (Dalloul et al., 2003; Dalloul 
and Lillehoj, 2005; Lee et al., 2007).  Probiotic supplementation has been shown to impact 
Eimeria infection by reducing oocyst shedding, increasing body weights, and increasing 
secretion of Eimeria specific antibodies in broilers infected with E. acervulina and E. 
tenella, however, the role of humoral immunity during a coccidiosis infection is still being 
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defined (Dalloul and Lillehoj, 2005).  We hypothesized that probiotic administration would 
increase IgG secretion systemically in response to coccidiosis.  The objective of this study 
was to evaluate how probiotic administration affects the humoral immune status of the bird 
compared to and when administered with ionophores and coccidiosis vaccination during an 
Eimeria infection.  
Materials and Methods 
Birds and Experimental Design 
 On day-of-hatch, Cobb 500 male chickens were obtained from a local commercial 
hatchery, placed into floor pens with 50% fresh pine shavings and 50% built up litter, and 
provided supplemental heat to simulate industry rearing conditions.  The birds were 
provided water via a nipple drinker system, which dispensed the probiotic, and were fed a 
diet shown to enhance performance of birds administered a coccidiosis vaccination using 
the following feeding program: starter phase (D1-15), grower phase (D15-29), finisher 
phase (D29-32) and withdrawal phase (D33-42) (Lee et al., 2009).  The ionophore and 
challenge were administered via the feed.  The experiment was conducted in a broiler 
rearing facility at the Texas A&M University Poultry Science Teaching, Research, and 
Extension Center, and animal care and husbandry were provided according to an approved 
Texas A&M Institutional Animal Care and Use protocol.   
 The experimental design used a 3x2 factorial ANOVA design with 3 coccidia 
control methods (control, ionophore and coccidiosis vaccination) and 2 probiotic groups 
(probiotic and no probiotic) to determine how the administration of probiotic and coccidia 
control methods affect avian gut morphology.  Individual treatment groups were negative 
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control, probiotic only, vaccination only, vaccination with probiotic, ionophore only, and 
ionophore with probiotic.     
Eimeria Challenge 
A field strain of Eimeria oocysts derived from a local broiler production facility 
was used to challenge the birds.  Species present included: E. acervulina, E. mivati, E. 
maxima, and E. tenella.  Two feed challenges were administered: on day 14 (50,000 
oocysts per bird) and on day 36 (750,000 oocysts per bird).  
Probiotic Administration 
A commercially available probiotic (Poultry Star
®
, Biomin, GmbH,
 
Herzogenburg, 
Austria) was administered at a concentration in accordance with the manufacturer’s 
recommendations (20 grams per 1,000 broilers) to the appropriate treatment pens in 
drinking water by utilizing an independent watering system.  Species present in the 
probiotic were Enterococcus faecium, Pediococcus acidilactici, Bifidobacterium animalis, 
and Lactobacillus reuteri.  Probiotic was administered intermittently from day of 
placement through day 2, days 9-10, 13-15, 25-27, and 32-33, which corresponded with 
each feed change.     
Ionophore Administration 
The ionophore, monensin (Coban-90, Elanco Animal Health, Indianapolis, IN), 
was added to the feed per manufacturer’s recommendations (90 grams per ton) according 
to the treatment group.  On day 33 the ionophore was removed from the feed to create a 
withdrawal ration to simulate industry methods.   
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Vaccination 
Vaccinated birds received Coccivac®-B (Intervet/Schering-Plough Animal 
Health/Merck and Co., Inc., Whitehouse Station, NJ), a non-attenuated live oocyst 
coccidiosis vaccine for use in broiler chickens.  The vaccine was applied using a 
Spraycox
®
 II cabinet (Intervet/Schering-Plough Animal Health/Merck and Co., Inc., 
Whitehouse Station, NJ).  Before placement, the birds were allowed to preen for an hour 
under bright light.   
Blood Collection and Processing 
 On days 6, 22, 36 and 43, blood samples were taken using venipuncture in the wing 
vein of 8 broilers per treatment group and deposited into 2 mL snap-cap microcentrifuge 
tubes (Eppendorf North America, Hauppauge, NY).  The blood samples were allowed to 
clot overnight at 4ºC.  The tubes were centrifuged at 2,000 x g for 2 minutes, the serum 
was removed, alliquotted into fresh microcentrifuge tubes, and stored at -80ºC for later 
antibody analysis.  
ELISA 
 Serum IgG concentrations were determined using a chicken-specific IgG ELISA 
quantitation kit (Bethyl Laboratories Inc., Montgomery, Tx).  The ELISA procedure was 
carried out according to manufacturer protocol and absorbance was measured at 450 nm.  
The concentration of IgG was determined using standard curves generated from IgG 
standards, run on the assay microtiter plate and were expressed as absorbance 
(Mountzouris et al., 2010).    
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Statistical Analysis 
 Data were measured using a factorial ANOVA and main effect means were deemed 
significant at P ≤ 0.05.  In cases where significant interactions were observed, data was 
subjected to a one-way ANOVA.  All means were separated using a Duncan’s Multiple 
Range Test.  Statistical analysis was completed with the SPSS statistical software package 
(Chicago, IL).   
Results and Discussion 
 Upon exposure on day 14, the vaccinated birds had significantly higher levels of 
IgG in serum compared to ionophore treated and control birds (Table 4-1).  During vaccine 
administration, the vaccinated birds were exposed to a level of that should have been 
immunogenic. By day 22, the vaccinated birds had increased IgG levels systemically, 
which was most likely due to the vaccine.  These data are supported by oocyst output data 
from this trial, which showed that vaccinated birds had two peaks of cycling before day 24 
(Klein et al., 2008).  Meanwhile, on day 36, the ionophore birds had significantly higher 
IgG levels compared to the control birds.  Chicken IgG is the predominant antibody during 
antibody responses that occur after the first exposure to an antigen (secondary, tertiary, 
etc.) (Abbas and Lichtman, 2006).  After the ionophore was removed from the feed on day 
33, the birds could have been undergoing an immune response to the day 36 challenge.  By 
day 36, this could have been a secondary antibody response, because the oocyst output 
data also shows a peak in oocyst cyling observed in ionophore treated birds after day 24 
(Klein et al., 2008).  The interference with immunity development from ionophore use has 
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been noted in previous research (Chapman, 1999; Chapman et al., 2004; Klein et al., 
2008).   
On day 22, non probiotic birds had greater IgG secretion compared to probiotic 
birds, which could indicate that the probiotic limited the exposure of the Eimeria parasite, 
inhibiting the development of a systemic humoral immune response (Table 4-1).  When 
Dalloul and colleagues (2003) evaluated antibody secretion during a coccidiosis infection 
between control and Lactobacillus-based probiotic fed birds, they also found that non 
probiotic birds had significantly higher antibody levels in intestinal secretions when 
compared to probiotic birds, though their serum antibody levels were not different (2003).  
They concluded that after infection, permeability across the mucosal barrier would increase 
and the pathogen would easily penetrate the submucosa, reaching the lamina propria where 
most of the antibodies producing B cells are located.  The data indicated that while higher 
antibody levels can indicate the effectiveness of antibody producing cells, they do not 
necessarily reflect resistance to infection.  
 These data support that coccidiosis vaccination does induce protective immunity 
earlier during production than other control methods.  The late peak of chicken IgG in the 
ionophore treated birds also supports previous research that indicates that ionophores can 
delay exposure to Eimeria, leaving the birds more susceptible to infection during the 
withdrawal phase. These data also indicate that current coccidia control methods and 
probiotics can have an effect on the humoral immune status of the bird, and may not just 
focus locally in the intestine, though the specific mechanisms by which the treatments 
interact to affect humoral immunity need to be investigated further.   
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Table 4-1.  Chicken IgG in serum shown as absorbance (450 nM) for each sample 
collection day.   
Treatment  Absorbance 
Control Measure Probiotic Day   6 Day 22 Day 36 Day 43 
Control  Control 0.553 0.371 0.397 1.103 
Control Probiotic 0.664 0.224 0.443 1.039 
Vaccine Control 0.556 0.483 0.547 1.137 
Vaccine Probiotic 0.574 0.346 0.421 0.870 
Ionophore Control 0.496 0.300 0.593 0.986 
Ionophore Probiotic 0.605 0.341 0.514 1.103 
            
Main Effects           
Control   0.609 0.298
b
 0.420
b
 1.071 
Vaccine   0.565 0.415
a
 0.484
ab
 1.007 
Ionophore   0.551 0.321
b
 0.554
a
 1.044 
            
  Probiotic 0.614 0.304
b
 0.459 1.007 
  Non Probiotic 0.535 0.385
a
 0.513 1.075 
a,b Means of main effects with different subscripts differ significantly at P≤0.05 
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CHAPTER V 
CONCLUSIONS 
 Coccidiosis continues to be a relevant disease to the commercial poultry industry 
due to the severe economic impact it has on producers.  The parasite Eimeria is ubiquitous 
among commercial poultry rearing facilities, due the nature of poultry rearing.  
Confinement, high stocking density, and litter conditions all contribute to the efficacy of 
the parasite among poultry flocks (Williams, 2002).  Consequently, the presence of 
Eimeria in the future is certain, so the development of prevention and control strategies are 
critical to facilitating the success of poultry producers. 
 Historically, coccidiosis control methods consisted of the use of in-feed 
anticoccidial drugs, like ionophores.  These prophylactic treatments have been and still are 
widely used as a means of coccidia control in the commercial broiler industry, because the 
drugs can eliminate the parasite before it is able to invade the intestine and cause damage 
to the intestine that could translate into losses for the poultry producer (Allen and Fetterer, 
2002).  Parasite resistance to ionophores is now well documented and widespread, which 
limits their effectiveness (Shirley et al., 2005).  Producers continue to use ionophores 
because little research is being done to produce new, more effective anticoccidial drugs.  
Recent research has been geared toward developing effective coccidiosis vaccines 
to control the parasite. Several types of vaccines are available, but the most effective are 
live oocyst vaccines (Rose and Hesketh, 1987; Shirley, 1989).  Live oocyst vaccines are 
either attenuated or non attenuated, and may contain different species of Eimeria, 
depending on the type of bird being vaccinated, and also on environmental factors, like 
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geographic location.  Coccidiosis vaccinations have been shown to provide the bird with 
long lasting immunity early during production, but in order to protect a bird from Eimeria, 
the vaccine must induce an immune response to the species of Eimeria the bird will be 
exposed too (Chapman, 2000).  Because immunity to one species of Eimeria does not 
protect against other species, vaccines must include multiple species.  Commercial poultry 
producers are hesitant to use coccidiosis vaccines because bird performance has been 
shown to suffer during vaccination (Allen and Fetterer, 2002).   
Probiotics are defined as direct fed microbials, and when ingested, probiotics can 
occupy niches in the gut, and competitively exclude pathogens (Fuller, 1989; Dalloul and 
Lillehoj, 2005).  Probiotics have been shown to increase bird performance, digestive 
function by improving the integrity of structures in the gut, facilitate resistance to 
infection, and affect antibody secretion (Dalloul and Lillehoj, 2005; Eckert et al., 2010).  
Improvements in gut morphology, like increased surface area or deepened crypts, can be 
indicative of greater absorptive and digestive capacity, as well as enterocyte turnover 
(Samanya and Yamauchi, 2002; Awad et al., 2009).  These effects could not only facilitate 
pathogen resistance, but also they could ameliorate the cell damage incurred during an 
Eimeria infection, which leads to weight loss due to malabsorption in birds.  Probiotics are 
capable of excluding opportunistic pathogens because they promote a healthy balance of 
normal bacteria (Dalloul and Lillehoj, 2005).  Probiotics could help prevent necrotic 
enteritis which often results from co-infections of Clostridium perfringens and E. maxima 
(Park et al., 2008).   
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Probiotics have been reported to modulate the immune system (Lillehoj and Choi, 
1998; Dalloul et al., 2003; Chichlowski et al., 2007).  However, little research exists to 
specifically evaluate how probiotics interact with current coccidia control methods, like 
ionophores and coccidiosis vaccination, to determine if probiotics could improve the 
effectiveness of ionophores or vaccines in mediating a coccidiosis infection, or if 
probiotics alone could mediate the infection.  The current research focused on the effects 
of feeding probiotics, combined with current coccidia control methods, to evaluate the 
impact of these factors on gut morphology as well as the humoral immune status of the 
bird.  
When examining gut morphology, we found that the addition of probiotics to the 
vaccine caused several significant interactions in the duodenum before and after the first 
feed challenge.  Pre challenge data suggested that the probiotic, when added to the vaccine, 
may have limited enterocytes exposure to the Eimeria by adhering to the intestinal mucosa, 
thus limiting exposure of enterocytes to the parasite, and decreasing the influx of immune 
cells in the lamina propria in response to the vaccine.  On day 6, vaccinated birds had a 
significantly higher villus height to crypt depth ratio when compared to ionophore treated 
birds, which is associated with improved performance (Yang et al., 2007; Awad et al., 
2009).  These data could suggest that the vaccine did not cause cell damage in the 
duodenum, and that vaccinated birds had increased gut functionality due to improved villus 
height, villus width and villus surface area (Aptekmann et al., 2001).  In the lower ileum, 
vaccinated birds had significantly deeper crypts and lower villus height to crypt depth 
ratio, which indicates increased enterocyte production, however, villus height, width, and 
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surface area were not increased, suggesting there was some cell damage occurring in the 
vaccinated groups compared to the control groups, and perhaps the enterocytes are 
compensating for cell damage (Ruff and Wilkins, 1980; Yun et al., 2000).  
Post challenge, the addition of probiotic to the vaccine significantly increased villus 
height in the duodenum, and vaccinated birds had significantly increased lamina propria 
thickness compared to ionophore and control birds.  These data suggest that probiotics 
could benefit gut morphology by restoring absorptive capacity to the gut after an Eimeria 
challenge (Awad et al., 2006).  In the lower ileum, vaccinated birds had decreased surface 
area and increased crypt depth compared to the control birds post challenge; similar to 
what was seen in the vaccinated birds pre challenge.  The vaccine may not be fully 
protecting the birds from infection post challenge in the lower ileum, possibly due the 
difference in Eimeria localizing in the lower ileum.  The morphology of the lower ileum 
suggests that the lower ileum had decreased capacity and greater enterocytes production 
when compared to the morphology of the duodenum.  Eimeria in the lower ileum may be 
causing more cell damage, resulting in poor gut morphology (Dunsford et al., 1989).        
 Observations in the ionophore birds in the duodenum and lower ileum suggest that 
the ionophore could have been protecting the birds from the Eimeria until the feed was 
removed on day 33.  The increase in lamina propria thickness could indicate an influx of 
immune cells by day 43, while the decreased villus height could have been caused by a 
parasite invasion (Dunsford et al., 1989; Tellez et al., 1993).  The data support that 
ionophores can delay exposure of the birds to the parasite, and when the ionophore was 
removed the birds were open to infection late in production.   After ionophore removal on 
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day 33, lamina propria tissue in the duodenum and lower ileum significantly increased 
compared to vaccinated birds.  Also, ionophore birds showed decreased villus height to 
crypt depth ratio compared to control birds on day 36, which suggests that the ionophore 
birds had increased enterocyte production, possibly to regenerate damaged cells (Ruff and 
Wilkins, 1980).  The ionophore treated birds also peaked in chicken IgG secretion on day 
36, indicating there could have been an increase in the invasive potential of Eimeria at that 
time, which is supported by oocyst shedding data from this trial, which will be discussed 
below (Dalloul et al., 2003; Klein et al., 2008). 
 The ELISA data indicates that the increase levels of IgG in vaccinated birds on day 
22 was due to the vaccine cycling.  The histology data strongly indicates that the ionophore 
birds had delayed exposure to the parasite until the ionophore was removed from the feed.  
The chicken IgG secretion data supports the histology data that after the ionophore was 
removed from the feed on day 33, the birds could have undergone a secondary antibody 
response by day 36.  The interference with immunity development from ionophore use has 
been reported, and previous research suggests that it could take as long as seven weeks to 
obtain complete immunity to some Eimeria species (Chapman, 1999; Chapman et al., 
2004; Klein et al., 2008).   
On day 22, non probiotic birds had greater IgG secretion compared to probiotic 
birds, which could indicate that the probiotic limited the exposure of the gut to the Eimeria 
parasite, delaying the development of a systemic humoral immune response.  Dalloul and 
colleagues (2003) saw similar results when they evaluated antibody secretion during a 
coccidiosis infection between control and probiotic fed birds.  They found that non 
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probiotic birds had significantly higher antibody levels in intestinal secretions when 
compared to probiotic birds, though their serum antibody levels were not different (Dalloul 
et al., 2003).  In another experiment, Dalloul and colleagues (2005) found that splenic 
lymphocytes in non probiotics birds secreted more IFNγ compared to probiotics fed birds.  
The investigators concluded that non probiotics birds do have an increased systemic 
immune response, possibly due to a more severe infection.  These data could suggest that 
the probiotics contribute to the ―immuno-suppressed tone‖ of the gut by delaying a 
systemic immune response (Mayer, 1997).   
Probiotics, coccidiastats, and coccida vaccination do affect gut morphology and 
chicken IgG secretion.  The need for improved methods of control for coccidiosis will only 
increase in the future as commercial poultry production grows, and probiotics may be a 
tool to help alleviate the negative effects of coccidiosis.  Probiotics could improve gut 
morphology, which increases the absorptive capacity of the gut, as well as maintains a 
healthy balance of normal microbial flora, which helps to prevent co-infection.  Also, IgG 
secretion data suggests that the coccidiosis vaccination produced an immune response in 
broilers earlier than in ionophore treated birds, which means vaccinated birds were 
protected from the Eimeria challenge. These factors all present mechanisms by which 
producers could alleviate the negative effects of coccidiosis. 
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